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CHAPTER 1
INTRODUCTION￿￿
1. Means to achieve a reduction of the inflammatory response in cardiac surgical
patients
The generalized inflammatory response that occurs after cardiac surgery, elicits a
combined reaction from at least the immune system, the coagulation system and the
endothelial cell system. Activated leucocytes play a key role in this process by their
interaction with the endothelium, by their interaction with the cardiopulmonary
bypass circuit, and by their role in reperfusion injury, where they form platelet-
leucocyte complexes. To minimize or even prevent postoperative tissue injury, it is
thus attractive to target the leucocytes. This has been tried with various methods for
nearly all stages of the inflammatory pathway. Currently, the most important
strategies focus either on the prevention of leucocyte activation, or on the modulation
of the inflammatory response, or on ultrafiltration techniques.
Leucocyte activation may be prevented with heparin coated bypass circuits,
which reduce contact activation and possess an enhanced biocompatibility. However,
in a large European trial, clinical benefits could not be demonstrated in low-risk
patients.
1 In high-risk patients, the use of a heparin coated bypass circuit reduced the
time for postoperative ventilatory support and intensive care unit stay,
2 but this could
not be confirmed in another study.
3
Pharmacological agents may also prevent leucocyte activation. A serine protease
inhibitor with a variety of actions, aprotinin, is frequently used. Aprotinin and
prednisolone have been found to attenuate the generation of tumor necrosis factor and
the upregulation of leucocyte adhesion molecules.
4 A meta-analysis showed that
aprotinin, besides a reduction in blood use, reduced perioperative mortality.
5
However, two recently published studies could not demonstrate an anti-inflammatory
effect of aprotinin,
6,7 although postoperative blood loss was reduced. Due to the cost
and to the sensibilisation that occurs in 5% of the patients, aprotinin is generally
reserved for redo-operations.
Pharmacological agents are also used to modify the inflammatory response. For
this purpose corticosteroids, and particular dexamethasone, are often used.
Corticosteroids probably change the cytokine balance from proinflammatory to anti-
inflammatory.
8 Corticosteroids reduce leucocyte activation and pulmonary leucocyte
sequestration.
4,9 Although dexamethasone has been shown to decrease the
concentration of C-reactive protein on the first postoperative day, clear clinical
benefits in terms of postoperative oxygenation, time on mechanical ventilation, or
intensive care unit stay have not been demonstrated.
10-12 Use of dexamethasone may
even be detrimental by delaying early postoperative tracheal extubation, and initiating
postoperative hyperglycemia.
11 In addition, there is concern about the systemic
effects, for example the associated immunosuppression.
A relative novel pharmacological agent is the phosphodiesterase inhibitor
pentoxifylline, which has recently been used in a porcine model of lung
transplantation.
13 In this animal study, the use of pentoxifylline was as effective as
leucocyte depletion in preventing reperfusion injury. Several clinical studies are
available in humans during cardiac surgery that also demonstrate an effect on
pulmonary leucocyte sequestration after cardiopulmonary bypass.
14,15 However,
whether pretreatment with pentoxifylline will improve outcome in patients remains to
be elucidated. Pentoxifylline pretreatment in cardiac surgical patients attenuated a
postoperative deterioration of endothelial, renal, and liver function, but in a patient￿
group at high risk of systemic inflammatory response after cardiac surgery
supplemental pentoxifylline treatment did not reduce mortality.
16,17
Ultrafiltration techniques are used to restore the intraoperative fluid balance and
to reduce the inflammatory response. This approach is based on the idea that
ultrafiltration removes factors that trigger the inflammatory response. Ultrafiltration
has found a place mainly in paediatric cardiac surgery where it has been shown to
reduce body water, and to increase the haematocrit.
18 In adults however, the effects
are less clear and in a recently published study comprising 3,988 patients who
underwent coronary artery bypass grafting, it was suggested that ultrafiltration may
have adverse effects on operative outcome.
19
Fat also contributes to postoperative tissue injury. Fat microemboli have been
demonstrated in brain tissue after cardiopulmonary bypass.
20 These microemboli were
related to the retransfusion of cardiotomy suction blood,
21 and were associated with
postoperative neurocognitive dysfunction. In addition, the role of fat on tissue injury
is underestimated, because fat microemboli have not only been demonstrated in brain
tissue after cardiopulmonary bypass, but also in lung and renal tissue.
22,23
Cell savers are increasingly used to process cardiotomy suction blood, but these
devices might be less than ideal for several reasons. First, fat is not completely
removed by cell savers. Second, their use is expensive and requires attention and time
to process. Third, processed cell saver blood contains increased levels of interleukin-I
and activated leucocytes, which may aggravate the inflammatory reaction associated
with cardiopulmonary bypass.
24 Kaza et al. found that cell savers were not more
effective than a filter after the cardiotomy reservoir for the elimination of small and
large fat emboli.
25
Therefore leucocyte and fat depletion by means of a filter may offer a good and
practical alternative to modify the postoperative inflammatory response in cardiac
surgical patients. The aim of this thesis is to demonstrate that leucocyte and fat
filtration, applied in the setting of cardiac surgery, has a beneficial effect on
inflammatory markers and postoperative organ injury.
2. History of leucocyte filtration
Various aspects of leucocytes as markers of infection were already known in the
beginning of the 20
th century. For example, Gibson, a surgeon, wrote in 1906 in the
first clinical paper on leucocyte differential count that “... the differential blood count
and its relation to the total leucocytosis is today the most valuable diagnostic and
prognostic aid in acute surgical diseases that is furnished by any of the methods of
blood examination.”
26 In 1928, Fleming, a pathologist, was the first to use a cotton
wool plug as a filter for the removal of leucocytes from blood.
27 His apparatus is
shown in figure 1, and consists of a bend glass tube with a constriction. Cotton wool
was introduced in the constricted limb of the tube and pressed down as tightly as
possible with a cork-borer. Blood was placed above the cotton wool and under
pressure forced through the cotton wool with a teat. The aim of Fleming was not the
modification of the patient’s inflammatory response, but he needed leucocyte depleted
blood as a diluent for certain tests in connection with the antibacterial power of
leucocytes. We demonstrate his apparatus, because the compressed cotton wool used
in his filter resembles the structure of a modern depth filter and the pressure applied
by the teat equals the pressure that may be generated to force blood through modern
leucocyte depletion filters.￿
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By the end of the second World War more was known about function and
properties of leucocytes. It became clear that it was undesirable to have white blood
cells in transfusion components. Thus, the history of leucocyte filtration has been
closely related to the history of blood transfusion. From the beginning of transfusion
medicine blood clots and debris were observed in transfusion bottles. This remained
the case even after the introduction of citrated blood in 1914 by Hustin.
28 It was
therefore necessary to filter the blood just before transfusion. This was initially
accomplished by pouring the blood over gauze swabs, which was not only a
cumbersome and messy undertaking, but also resulted in contamination of the blood.
However, in 1939 several types of filter were in routine use, all allowing sterile
processing of the blood.
29 These filters consisted of glass beads in a glass cylinder and
were to be attached in line to the tubing of the transfusion system.
In the second World War stainless steel wire cloth incorporated in a glass
cylinder was used.
30 Although these filters were intended to be disposable, their cost
was high. They were therefore often cleaned after use, which was of course not easy.
From then on the filtering of the blood became rapidly more sophisticated and less
expensive, and from 1950, 230mm disposable filters were standard employed
throughout the world.
In 1961 Swank accidentally made an important observation while studying blood
viscosity in a model of small blood vessels. His observation served as a milestone for
the rapid development of transfusion related filtration techniques, because it
demonstrated the importance of leucocyte removal. He found, using a microfilter as
model (figure 2), that very high pressures were necessary to force blood that was
stored in acid-citrate-dextrose for 2 to 10 days through the filter. Microscopic
examination of the filters revealed that many openings were occluded by debris and
aggregates of platelets and leucocytes.
31 Swank then passed the old blood through a
glass  wool  filter  and  found  that  after this procedure the pressure to force the blood￿
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through his experimental micro-filter was similar to that of fresh blood. Most of the
aggregates in the glass wool filter were less than 50 mm in size on microscopic
examination and he called them micro-aggregates. A second observation was that
plasma, that had been spun free of white blood cells and platelets did not require high
pressure to force it through the microfilter, even after storage for 10 days. On the
other hand, plasma containing leucocytes and platelets exhibited the same filtration
problems after storage for 10 days as shown by whole blood. Dacron and polyester
filters in wool form also removed the micro-aggregates effectively. In the late 1970s
specific filters for routine leucocyte removal in clinical practice have been developed.
3a Leucocyte depletion filters
The first generation of leucocyte depletion filters for routine use that became
available in the 1970s were made of cellulose and had a leucocyte removal rate of
about 98%. They were developed for blood bank use to obtain leucocyte depleted
blood for specific purposes such as the prevention of non-haemolytic transfusion
reactions and viral transmission. However, these filters appeared also to activate
complement C3, which promotes vasoconstriction and increases capillary
permeability.
32 A second drawback was that the efficacy of leucocyte removal was
determined by the flow over the filter. Filtration was therefore a slow process and
took about 30 minutes for one unit of red blood cells.
Over the last years however, a new generation of filters has become available
which combines rapid flow with an excellent leucocyte removal rate. These new
filters remove 99,995% of the leucocytes from the blood, but for cardiopulmonary
bypass perfusate this is somewhat lower with a 96.8% removal of leucocytes.
33 The
improved flow properties allow them to be used in settings with higher fluid
requirements. For an explanation of these improved flow properties, some aspects of
the biomaterials and design that are used will now be discussed.
The design of a leucocyte depletion filter is of course a compromise between
several properties. At this moment depth and screen filters are used. In depth filters,
the filter material has the form of compressed wool fibres. These filters are made of
polyester or sometimes polyurethane, and promote adhesion of the leucocytes
throughout the filter material. In contrast, screen filters consist of layers of woven
polyester filter material. In this type of filter the leucocytes are bound to subsequent 
layers of filter material. Most leucocytes are thus trapped at the outermost portion of
the filter and this may increase the resistance over the filter.
The way leucocytes are trapped inside the filter influences filter efficacy and
capacity. At least 4 active and passive mechanisms have been described (figure 3).
34
The most important mechanism is adhesion. The negatively charged leucocytes are
attached to the filter material by Van der Waals- and electrostatic forces. It is, there-
fore, an active process from the side of the leucocytes. The advantage is that a larger
pore size is possible in the filter with subsequent higher flow rates. Passive
mechanisms of leucocyte entrapment are blocking, bridging and interception. By
blocking, the leucocyte is trapped in a pore between two fibres. By bridging, 2 or
more leucocytes form an aggregate in a pore between two fibres. By interception,
leucocytes are mechanically trapped in the dead space around the fibres. All these
mechanisms may occur together.
Thus, properties of the filter material like surface charge and hydrophilicity
greatly determine the efficacy of the filter. Therefore, coating of the filter material is
often used to improve the filter efficacy. A coating of methacrylate creates a more
positive surface charge that results in a stronger bond with the negatively charged
leucocytes.
35 Hydrophilicity is important for optimal contact between the leucocytes
and the fibres and thus for the subsequent adhesion. This implies that optimal
leucocyte depletion can only occur if the whole filter is exposed to blood, which
means that de-airing before use must be carefully performed. Insufficient de-airing
results in disturbances of optimal blood flow and thus in a reduction of filter efficacy.
Another effect of the physicochemical properties of the filter material is that
leucocytes appear predominantly to stick to the crossing points of the filter fibres.
36
Thus, more crossing points increase the efficacy of the filter. More crossing points
require thinner fibres. However, thinner fibres also lead to an increase in resistance
and thus to flow reduction.
The filter capacity depends on the construction of the filter, i.e. the available
surface and the thickness of the filter. A simple rule is that the log of the leucocyte
reduction in the filter relates to the thickness of the filter material.
36 The current
generation of leucocyte depletion filters may be pressurized up to 300 mmHg. This
allows rapid transfusion in a clinical setting, but decreases the efficacy as it has been
shown that a longer contact time of the leucocytes in the filter increases the filter
efficacy.
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The efficiency of the filters decreases over time as the filter becomes saturated
with cells and debris.
37,38 For a blood cardioplegia filter this results in a pressure
gradient of about 10mmHg at a mean flow of 300 ml.min
-1. In up to 2500 ml about
75% of the leucocytes were removed.
39
One major drawback of the leucocyte depletion filters is the concomitant removal
of platelets. Thus, application of leucocyte depletion filters may interfere with blood
coagulation. This is a problem of all leucocyte depletion filters as generally 40% of
the platelets that pass through the filter are trapped.
40 Allen et al. demonstrated a
significant difference in platelet counts by drawing samples simultaneous up- and
downstream of the filter.
41 Nonetheless, a certain platelet deposition on the polyester
fibres of the filter facilitates the adherence of the leucocytes.
42 It appears that platelets
have a higher affinity for the filter material than leucocytes,
43 while platelets have
active surface receptors so that they rapidly establish a strong bond with leucocytes.
44
Another aspect of the removal of platelets is that platelets also are responsible for the
release of different vasoactive substances. Therefore, removal of platelets could also
lead to a reduction in thromboxane release and therefore to a reduction in
vasoconstriction.
45
3b.  Fat removal filters
Little is known about the clinical filtration of fat emboli. As a consequence, part
of the technology for fat filtration is derived from the diary food industry and water
cleaning processes. For example, hydrophobic cotton fibres, which are obtained by
acylation of cellulose, have a high selective affinity for fat in an aqueous medium.
46
They are used for water processing, but resemble the first generation of leucocyte
depletion filters. Fat filtration appears to be technically difficult, because the process
is temperature dependent. A fat removal filter removed 50% of the fat load at 37
oC
which increased to 80% at 10
oC, due to the increased viscosity of the fat. However, at
lower temperatures, haemolysis of the blood and clogging of the filter were
observed.
47
A standard polyester arterial line filter with a 40 mm pore size does not seem to
filter fat during cardiopulmonary bypass.
48 However, passing cardiotomy suction
blood through a standard 30 mm cardiotomy suction filter and subsequently through a
21 mm arterial line filter almost completely eliminated fat.
25 These findings suggest
that the filter pore size is a major determinant for fat filtration. In 1973, Arrants et al.
used an ordinary blood filter with a pore size of 35-40 mm, but they could not
demonstrate a clinical effect.
23 Thus, a small pore size is necessary and supports the
concept that fat globules are highly deformable.
Based on the work of Swank, Hill et al. used a dacron wool filter in the
cardiotomy suction line.
49 This resulted in a reduction in postoperative cerebral
dysfunction. Clark et al. studied the fat filtration characteristics of a packed polyester
wool filter.
50 They found that significant quantities of solids, two thirds of which were
fat, were removed by the filters. Their findings about the efficacy of polyester for the
removal of fat are in line with a more recent study evaluating a specific fat removal
filter.
51 This filter is also made from polyester fibers, but contains less filter material
to improve the flow properties than the leucocyte removal filter from which it was
derived. However, a specific coating of the filter material should compensate for this.
In a laboratory study with reconstituted outdated blood and soya oil, the filter
removed fat, but was less effective than a leucocyte depletion filter.
51￿
This fat removal filter was also used in conjunction with a leucocyte removal
filter for processed cell saver blood.
52 This combination again emphasizes the small
pore size that is needed for fat filtration. However, a small pore size reduces the flow
properties of the filter. Better coating of the filter fibers may offer an alternative.
Therefore, sorbent technology which is currently used in dialysis filters, may hold
promise for the future as a result of improved coating techniques.
53
4. What is the evidence that leucocyte and fat depletion filters are beneficial during
cardiac surgery?
In the 1980s attention was focussed on what happened during ischaemia and
reperfusion in organs. Engler et al. demonstrated in dogs that the myocardial stunning
which was observed after occlusion of the left anterior descending coronary artery up
to 5 hours, resulted largely from reperfusion injury. They observed during reperfusion
an incomplete restoration of the blood flow in the microvasculature of the heart. This
so called no-reflow phenomenon was associated with capillary leucocyte plugging
and endothelial cell protrusion and was based on an acute inflammatory response.
54
This revealed a central role for leucocytes and Engler et al. hypothesized that
leucocyte depletion might be beneficial in the setting of ischaemia and reperfusion.
They tested this hypothesis in their dog model and found that reperfusion with
leucocyte depleted blood almost completely prevented reperfusion injury. In addition,
leucocyte depletion prevented the increases in tissue water content seen in control
hearts and decreased the incidence of ventricular arrhythmias.
55 Shortly after these
observations, Kutsumi et al. applied leucocyte filtration clinically in the setting of
ischaemia and reperfusion. After percutaneous transluminal coronary angioplasty
(PTCA) they drew blood from the femoral vein which they passed through a
leucocyte filter before it was injected in the coronary vessels. This procedure resulted
in a significant reduction in reperfusion arrythmias.
56
These findings on reperfusion injury stimulated research in the setting of heart
and lung transplantation. Here, the beneficial effects of leucocyte depletion were
quickly recognized and gradually found a clinical application during lung
transplantation,
57 and as an adjunct to blood cardioplegia in the setting of cardiac
transplantation.
58 Preliminary studies in dogs after cardiac transplantation indicated
that reperfusion with leucocyte depleted blood increased stroke work and cardiac
output,
58,59 and were soon followed by clinical studies that showed minimal
histological changes and lower myocardial creatinine phosphokinase levels after
reperfusion with leucocyte depleted blood.
60 However, clinical effects in terms of
cardiac function were less clear.
As a result of the effects of leucocyte depleted reperfusion during cardiac
transplantation, blood cardioplegia filters were developed. Only the target organ is
depleted, while total body and side effects are minimal. This stimulated research in
the setting of ischaemia and reperfusion and clinical studies were extended to
emergency cardiac operations in patients who developed an acute myocardial
infarction. Sawa et al. applied leucocyte depleted blood cardioplegia in elective and
emergency patients.
61 The results of leucocyte depletion were better in emergency
patients than in elective patients. Lower peak myocardial creatinine phosphokinase
levels were measured in the emergency patients and less dopamine was required at
weaning off cardiopulmonary bypass. This study was extended to patients with left
ventricular hypertrophy, defined as a left ventricle mass >300 g, to investigate if￿
￿
￿
reperfusion injury was attenuated by the application of a leucocyte depletion filter for
blood cardioplegia that was administered for the first 10 minutes after aortic cross
clamp release.
62 Left ventricular biopsies had significantly lower scores for myocyte
damage and for endothelial cell damage of capillaries in the leucocyte depleted group.
The leucocyte depleted group also had lower myocardial creatinine phosphokinase
levels, and needed less dopamine for weaning off cardiopulmonary bypass. No side
effects of leucocyte depletion were noted. In a subsequent study the patients with left
ventricular hypertrophy were divided in a group with a long and in a group with a
short aortic cross clamp time.
63 The effects of leucocyte depletion were more
pronounced in the group with the longer cross clamp times. Roth et al. also studied
patients with depressed left ventricular function, using serial leucocyte depletion
filters in the blood cardioplegia line.
64 Less dopamin was needed in their filter group,
that also showed an increased left ventricular ejection fraction. Another interesting
thing in this study was the use of two blood cardioplegia filters in line. The authors
wanted to achieve a high degree of leucocyte depletion and felt that the documented
efficacy of a standard blood cardioplegia filter was too low.
64 We also found that the
efficacy of a leucocyte depletion filter was lower if cardiopulmonary bypass perfusate
was used.
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These findings indicate that leucocyte depletion is more beneficial in patients that
are clinically in less favourable circumstances. It also indicates that the systemic
effects of leucocyte filtration are minimal.
A word of caution should be made with regard to the proper interpretation of the
clinical results in the earlier studies. At that time only transfusion filters and cell
separator technology were used for leucocyte depletion. The efficacy of these
technologies is less than the efficacy of the current generation leucocyte depletion
filters. Thus, the clinical effects may have been underestimated in the past.
Another important question that had to be resolved was how long leucocyte
depletion should be performed in order to prevent reperfusion injury. This question
was addressed by Breda et al.
65 They studied lung preservation in a rabbit model, and
found that reperfusion with leucocyte depleted blood preserved lung function. Then
they added again leucocytes to the perfusate and found that the addition of leucocytes
after one hour of reperfusion did not cause significant injury to the lung.
In contrast with the findings in isolated organ perfusion, Bando et al. were the
first to report a favourable systemic effect of leucocyte filtration.
66 They found in
dogs, subjected to cardiopulmonary bypass, a reduction of free radicals and a
preservation of pulmonary function by the application of a leucocyte depletion filter
in the cardiopulmonary bypass circuit. These findings were repeated by Johnson et al.
who also studied dogs during cardiopulmonary bypass, using a bubble oxygenator.
67
They found an improvement in pulmonary shunt in the filter group. In addition,
histological investigation of the lungs after cardiopulmonary bypass revealed lower
oedema scores in the dogs that had leucocyte depletion, which resulted in an
improved gas exchange. These two landmark studies served as a starting point
regarding the effects of systemic leucocyte depletion.
Most studies on systemic leucocyte depletion during cardiac surgery agree on the
fact that filtration reduces postoperative leucocyte counts.
37,67-69 However, there is
disagreement about the clinical effects on pulmonary or cardiac function. Some
studies reported a short term improvement in postoperative oxygenation. Palanzo et
al. found an improved arterial blood oxygenation. With 100% oxygen, patients in the￿
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leucocyte depleted group had an arterial oxygen tension of 54.9 kPa vs. 46.4 kPa in
the controls. The postoperative time on the ventilator was with 9.2 vs. 13.3 hours also
shorter in the leucocyte depleted group than in the control group.
70 Johnson et al.
reported a transient improved oxygenation in the leucocyte depleted group with a
transient improved intrapulmonary shunt (19% filter vs. 24% controls), which was in
agreement with their previous study on dogs.
71 Lust et al. also found a slight
improvement in arterial blood oxygenation.
72 Others however, did not find an
improved arterial blood oxygenation at all.
73 It should be noted that in all these studies
arterial line filtration during the whole period of cardiopulmonary bypass was used.
Several factors may explain the reported differences in filter efficacy. Amongst
them are the timing and duration of the filtration procedure during the operation and
the type of filter used. For example, leucocyte depletion is commonly achieved with a
filter in the arterial line throughout the cardiopulmonary bypass period.
37,70-74
However, using this procedure, high elastase levels have been demonstrated after the
filter in the arterial line.
73 Elastase is a marker enzyme for leucocyte activation. Mair
et al. found elevated systemic levels of elastase by the end of the filtration period,
74
and also Palanzo et al. could not demonstrate a reduction in systemic plasma elastase
levels when applying leucocyte depletion in the arterial line of the cardiopulmonary
bypass circuit.
70 These findings suggest that the leucocytes which were trapped in the
arterial line filter become extensively activated. However, it may also be possible that
activated leucocytes are preferentially trapped inside the filter. This was first
suggested by Thurlow et al. when they investigated the expression of antigens on
neutrophils using leucocyte-associated monoclonal antibodies.
75 In a subsequent small
scale study in humans they concluded that the application of an arterial line filter did
not result in a significant depletion of the leucocyte load during cardiopulmonary
bypass, but that according to their indirect measurements of superoxide the activated
forms of the leucocytes appeared to be depleted.
76
The good results of leucocyte depletion during reperfusion, the moderate results
of leucocyte depletion with an arterial line filter during the whole cardiopulmonary
bypass period and the limited capacity of the filters, prompted Hachida et al. to
remove the leucocytes from the circulation by a systemic filtration procedure in a
restricted but well aimed time span.
77 They applied leucocyte depletion only in the
reperfusion phase after aortic cross clamp release and reported an improved
pulmonary index after 3 and 6 hours. Matheis et al. also applied leucocyte filtration in
a short time period after aortic cross clamp release and found in the leucocyte
depleted group a reduction in inotropic support and a reduction in troponin-T
concentrations, indicating less myocardial damage.
78 However, Baksaas et al., using a
similar procedure, found a reduction in circulating leucocyte counts, but could not
demonstrate clinical differences with their control group.
79 They suggested that
filtration during release of the aortic cross clamp was too late, because a large
population of leucocytes was already activated at that time. Thus, timely and well
defined periods of leucocyte depletion may offer an advantage over generalized
procedures during the whole cardiopulmonary bypass period.
Does leucocyte depletion have effects on other organs? Tang et al. found a better
renal function in the leucocyte depleted group in cardiac surgical patients.
80
Davies et al. used an interesting approach.
81 They removed platelets and
leucocytes from patients by plasmapheresis preoperatively. This approach resulted in
a reduction of postoperative blood loss, an improved pulmonary function and a￿
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reduction in allogenic blood transfusion. However, their approach has not gained wide
acceptance because of the costs and complicated logistics involved. Moreover, it is
difficult to accept that a reduction of blood loss could be achieved in the absence of
platelets.
From the studies mentioned in this review it may be concluded that leucocyte
depletion has a beneficial effect on several clinical parameters. However, leucocyte
depletion filters are still relatively little used in routine practice. One explanation may
be that there are no large scale studies, which demonstrate the clinical effects of
leucocyte depletion in terms of reduced organ injury and length of intensive care unit
or hospital stay. There is only one study that comprises 100 patients and in this study
it was found that leucocyte filtration applied during all stages of cardiac surgery
reduced the inflammatory response after cardiopulmonary bypass, was cost-effective
and resulted in a shorter hospital stay.
37 However, this study was designed to compare
several anti-inflammatory strategies and was not intended to make an in depth
assessment of the effects of leucocyte filtration on perioperative organ injury.
The acceptance of fat processing may have a comparable course. Several studies
suggest that the major source of the cerebral microemboli that occur after
cardiopulmonary bypass is lipid droplets of the patient’s fat that drip into the blood in
the surgical field.
20,21 This lipid-laden blood is aspirated and then returned to the
patient via the cardiopulmonary bypass circuit. This was the reason for Arrants et al.
in 1973 to use a filter for the removal of fat.
23 An ordinary blood filter with a pore
size of 35-40 mm was inserted on either the arterial line of the bypass circuit or the
cardiotomy suction line or both. Despite a uniform postoperative rise in blood lipids
in all studied patient groups, the use of the filter was disappointing as pulmonary and
neurological complications did not decrease in the filter group.
Hill et al. used a dacron wool filter in the cardiotomy suction line.
49 They found a
reduction in postoperative cerebral dysfunction which was paralleled by a reduction in
cerebral microemboli on autopsy studies. Clark et al. studied the fat filtration
characteristics of a packed polyester wool filter when used alone in the cardiotomy
suction and in the arterial line during clinical extracorporeal circulation.
50 The total
lipid extracted from the cardiotomy filters averaged 376 ± 72 mg and from the arterial
line filters 512 ± 95mg. They concluded that significant quantities of solids, two
thirds of which were fat, were removed by the filters during cardiopulmonary bypass.
Most of the fat was derived from the cardiotomy suction system. Recently, Kaza et al.
placed an additional filter after the cardiotomy reservoir of the heart-lung machine
and looked for circulating fat.
25 There were no large emboli detected after the filter.
However, neurocognitive outcome was not measured. In a study in orthopaedic
patients after spine fusion, shed wound blood was retransfused either through a 40 mm
pore transfusion filter or through a leucocyte removal filter.
82 Leucocytes and fat were
measured after the filter. It appeared that a leucocyte removal filter was very effective
for the reduction of fat, but that use of a transfusion filter was ineffective.
Realizing that recycling shed blood with cardiotomy suction is an important
source of cerebral fat microemboli, Jewell et al. performed a pilot study in patients
undergoing cardiac surgery using a cell saver or unprocessed retransfusion of
cardiotomy suction blood.
83 They measured the circulating fat. Although they did not
find a difference in the postoperative use of blood or blood products, haemoglobin, or
bleeding between the two groups, they concluded that use of a cell saver resulted in
less fat being recycled during cardiopulmonary bypass. The findings of this study are￿
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in line with a previous study in dogs subjected to cardiopulmonary bypass.
84 An
arterial line filter, aimed to reduce leucocytes and fat, was compared with a cell saver,
used to process the cardiotomy suction blood. Less cerebral microemboli were
observed in the cell saver group. Interestingly, two different types of cell saver were
used in this study, which resulted in measurable differences in cerebral microemboli.
However, this was a small animal study and the results should be interpreted with
caution. In another small clinical study, cardiotomy suction blood and the residual
heart lung machine blood were processed by a cell saver.
52 The processed cell saver
blood was retransfused using a fat removal filter in conjunction with a leucocyte
removal filter. This approach resulted in an improvement of pulmonary function in
the filter group vs. unfiltered controls.
These studies suggest that techniques to reduce circulating fat are promising, but
further clinical studies are needed to demonstrate effects on outcome.
5. Outline of the thesis
The next four chapters of this thesis consider leucocyte filtration, chapters 6-8
consider the concept and the effects of fat filtration.
Conflicting results have been reported regarding the clinical effects of leucocyte
depletion using a leucocyte filter incorporated in the arterial line of the
cardiopulmonary bypass circuit. In chapter 2 a new approach is described. We used a
leucocyte depletion filter for the residual heart-lung machine blood that was
retransfused in the patient after cardiopulmonary bypass. The hypothesis was that
blood that is retransfused in a vein first passes the lungs. The lungs act as an
endogenous filter and remove activated leucocytes and debris from this blood. If these
activated leucocytes and debris were trapped in a filter this would result in less
pulmonary injury and improved postoperative lung function.
In chapter 3 we used the same approach in children. The hypothesis was that the
effects of leucocyte depletion would be larger than in adults as especially children
with a cyanosis would have less possibilities to cope with oxygen radicals that cause
postoperative tissue injury.
Chapter 4 addresses the important question whether a leucocyte depletion filter
removes all leucocytes, or more specific the activated leucocytes. Depletion of only
the activated leucocytes would be beneficial, because these cells play a major role in
the reperfusion injury that occurs in the patient after cardiopulmonary bypass as
explained in the introduction. In contrast, removal of all leucocytes may be harmful
and raise concern about infectious complications.
In chapter 5 the effect of several leucocyte depletion strategies is compared in
order to find the optimal approach for leucocyte depletion. The usual application of a
leucocyte filter in the arterial line of the cardiopulmonary bypass circuit, the
application of a filter in the retransfused heart-lung machine blood, and a novel
approach via a venous bypass line in the cardiopulmonary bypass circuit are
compared. This last approach was chosen because it would be easy to remove a filter
after its use from the circuit during the cardiopulmonary bypass procedure. This is
necessary because we feel that leucocytes that are trapped in the filter should
subsequently be removed from the circulation to prevent the release of activation
products.
Chapter 6 serves as an introduction to chapters 7 and 8 and gives an introduction
into the concept of fat filtration. There is evidence that leucocytes, fat and particulate￿
￿
￿
all contribute to postoperative tissue injury. It may well be that the concept of
leucocyte filtration has to be extended to include also fat and particulate.
In chapter 7 the clinical application of a recently developed fat depletion filter is
evaluated. This filter was positioned after the cardiotomy reservoir of the heart-lung
machine, and thus used for all the cardiotomy suction blood. This blood is known to
contain a large amount of fat globules.
In chapter 8 the effects of the fat filtration filter on biochemical markers of brain
injury during and after the operation are more closely investigated. Neurocognitive
dysfunction is common after cardiac surgery and it is known that cerebral fat
microemboli play a role in its origin.
In chapter 9 a summary and conclusions are given.
In chapter 10 a summary in Dutch is given.
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CHAPTER 2
LEUCOCYTE DEPLETION RESULTS IN IMPROVED LUNG FUNCTION
AND REDUCED INFLAMMATORY RESPONSE
AFTER CARDIAC SURGERY
Y. J. Gu, A. J. deVries, P. W. Boonstra, W. van Oeveren
The Journal of Thoracic and Cardiovascular Surgery 1996,112:494-500¢
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ABSTRACT
Leucocyte depletion during cardiopulmonary bypass (CPB) has been
demonstrated in animal experiments to improve pulmonary function. Conflicting
results have been reported, however, with clinical depletion by arterial line filter of
leucocytes at the beginning of CPB. In this study, we examined whether leucocyte
depletion from the residual heart-lung machine blood at the end of CPB would
improve lung function and reduce the postoperative inflammatory response. Thirty
patients undergoing elective heart operations were randomly allocated to a leucocyte-
depletion group or a control group. In the leucocyte-depletion group (n = 20), all
residual blood (1.2 L to 2.1 L) was filtered by leucocyte-removal filters and reinfused
after CPB, whereas in the control group an identical amount of residual blood after
CPB was reinfused without filtration (n = 10). Leucocyte depletion removed more
than 97% of leucocytes from the retransfused blood (p < 0.01) and significantly
reduced circulating leucocytes (p < 0.05) and granulocytes (p < 0.05) compared with
the control group. Levels of the inflammatory mediator thromboxane B2 determined at
the end of operation were significantly lower in the depletion group than the control
group (p < 0.05), whereas no statistical differences in interleukin-6 levels were found
between the two groups. After operation, pulmonary gas exchange function (arterial
oxygen tension at a fraction of inspired oxygen of 0.4) was significantly higher in the
leucocyte-depletion group 1 hour after arrival to the intensive care unit (p < 0.05) and
after extubation (p < 0.05). There were no statistical differences between the two
groups with respect to postoperative circulating platelet levels and blood loss, and no
infections were observed during the whole period of hospitalization. These results
suggest that leucocyte depletion of the residual heart-lung machine blood improves
postoperative lung gas exchange function and is safe to be used for those patients who
are expected to develop severe inflammatory response after heart operations.⁄
4
¥
INTRODUCTION
Cardiopulmonary bypass (CPB) induces a whole body inflammatory response
that leads to postoperative lung dysfunction.
1-2 This response is largely mediated by
the activation of polymorphonuclear leucocytes and by subsequent leucocyte
deposition and interaction with the lung endothelium.
3-7 During the initial phase of
CPB, leucocytes are activated by the contact of blood with foreign materials in the
extracorporeal circuit. After release of the aortic crossclamp in the late phase of CPB,
when heart and lungs are reperfused, activation of leucocytes and leucocyte-
endothelium interaction are intensified, leading to the impairment of lung function
and the induction of a postoperative inflammatory response known as the “post-
perfusion syndrome”.
8-9
Leucocyte depletion by means of filtration was originally used by blood banks to
prevent transfusion complications associated with donor leucoytes.
10-11 Recent animal
experiments demonstrated that leucocyte depletion in different heart operation models
reduces heart and lung reperfusion injury.
12-14 Conflicting results have been noted,
however, in reports of clinical use at the beginning of CPB of arterial line-filters with
leucocyte-depleting capacities.
15-19 Furthermore, there has been concern regarding the
simultaneous removal of platelets during leucocyte depletion, which could influence
postoperative haemostasis.
13,20
In this article, we report a study in which only the blood residual in heart-lung
machine was depleted of leucocytes, because this blood contains a considerable
number of activated leucocytes and is usually reinfused to patients immediately after
CPB. We examined whether leucocyte depletion from the residual blood at the end of
CPB would improve postoperative lung function and reduce the postoperative
inflammatory response. We also examined whether such a “partial” leucocyte
depletion method would minimize the major side effect in patients undergoing heart
operations, reduction of circulating platelets.
PATIENTS AND METHODS
Patients
After approval by the medical ethical committee in the University Hospital in
Groningen and informed consent from patients, 30 patients electively undergoing
either coronary artery bypass grafting, heart valve replacement or a combined
procedure were randomly allocated to a leucocyte-depletion group (n = 20) or a
control group (n = 10). Exclusion criteria were a history of allergy or recurrent
infection, reoperation, and emergency operation. The demographic data of patients in
both groups are summarized in table 1.
Anaesthesia was induced and maintained by intravenous infusion of sufentanil
citrate (1–3 µg/kg) and midazolam (0.05-0.1 mg/kg). Muscle relaxation was achieved
with pancuronium bromide (100–140 µg/kg). Cefamandol 2 g and dexamethason 1
mg/kg were administered after induction. Anticoagulation was achieved by
intravenous administration of bovine lung heparin at a dose of 300 IU/kg about 5
minutes before the start of bypass.ƒ
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CPB
The extracorporeal circuit consisted of roller pumps (Stöckert Instrumente,
Munich, Germany) and a microporous polypropylene membrane oxygenator (CML
Excel, Cobe Laboratories Inc., Lakewood, CO). Within 10 minutes of CPB initiation
at a flow rate at 2.4 L/min/m2, the aorta was crossclamped and 1 L of St. Thomas
cardioplegia solution (4°C) was infused into the aortic root to provide myocardial
preservation. During CPB, moderate hypothermia was induced to maintain the
nasopharyngeal  temperature  between  28  to  30ºC.  The  mean  arterial  pressure
was maintained  at 50 to 60 mmHg during CPB. Anticoagulation during CPB was
monitored by the celite activated clotting time (International Technidyne Co., Edison,
N.J.). After CPB, heparin was neutralised by protamine chloride (3 mg/kg).
Leucocyte depletion
Leucocyte depletion was achieved with the use of RC400 leucocyte-removal
filters (Pall Biomedical, Portsmouth, UK) designed particularly for leucocyte
filtration under high flow conditions in the operating room.
21 After the termination of
CPB, a total volume of 1200 mL to 2100 mL residual blood in the extracorporeal
circuit was collected into a blood transfution bag. In the leucocyte-depletion group,
the collected blood was filtered by two or three filters and reinfused before the end of
operation, whereas in the control group the residual blood was reinfused through the
venous transfusion line without leucocyte filtration.￿
w
￿
Lung function
Pulmonary gas exchange was measured by the partial arterial oxygen pressure
from blood samples drawn from the radial artery line and standardized at a fraction of
inspired oxygen of 0.4. Pulmonary haemodynamics exemplified by mean pulmonary
artery pressure (PAP) and pulmonary capillary wedge pressure (PCWP) were
measured through a Swan-Ganz catheter (Edwards, Baxter Healthcare Corp, Irvine,
CA) introduced percutaneously through the right internal jugular vein into the
pulmonary artery. Pulmonary vascular resistance (PVR) was calculated according to
the following fomula: PVR (dyne.sec.cm
-5
) = (PAP - PCWP) / CO x 80.
Other clinical parameters
Duration of postoperative intubation was recorded during each patient’s stay in
the intensive care unit. Blood loss was indicated by 24-hour chest drainage. In
addition, durations of stay in the intensive care unit and of hospitalization after
operation were obtained from hospital registration records.
Laboratory parameters
For laboratory haematologic tests and biochemical assays, blood samples were
taken from the indwelling radial arterial catheter at the baseline before operation, at
the end of CPB before transfusion of the leucocyte-depleted blood, at the end of
operation during skin closure, 1 hour and 3 hours after the patient’s arrival in the
intensive care unit, and at 6 am the next day in the intensive care unit. In addition,
prefiltration and postfiltration samples were taken from the transfusion bags to
determine the cell counts and calculate the rate of leucocyte removal.
Cell counts were determined by a cell counter (Cell-Dyn 610, Sequoia Turner,
Mountain View, CA) with a dilution of 1:250 for counting leucocytes and
granulocytes and of 1:25,000 for counting platelets. For the postfiltration samples,
leucocytes were counted by means of the Nageotte manual counting chamber or by
the cell counter with a dilution of 1:100.
For biochemical assays, plasma was obtained by centrifugation of whole blood at
1100 g and stored at -80°C until further determinations. Thromboxane was
determined by enzyme immunoassay (Cayman Chemical Company, Ann Arbor,
Mich) in plasma anticoagulated with citrate and indomethacin. Interleukin-2 and
interleukin-6 were determined by enzyme immunoassay (Quantikine, R&D Systems
Europe, Abingdon, UK) from citrated plasma.
Statistics
Data processing as well as statistical tests were performed with the StatView
software (Brain-power Inc, Calabasas, CA). Data are expressed as mean plus or minus
standard error of the mean unless otherwise indicated. A repeated-measures analysis
of variance was used to determine the difference between the two groups. Student’s t
test or Mann-Whitney test was used for analysis of difference between the two groups
at each sampling or recording time point. A p-value less than 0.05 was considered
statistically significant.￿
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RESULTS
There were no significant difference between the leucocyte-depletion group and
the control group with respect to duration of CPB and aortic crossclamp time. All
patients recovered uneventfully after operation.
Leucocyte reduction in residual machine blood
The average leucocyte count determined from the residual machine blood before
filtration was 5.76±0.44 x 10
9/L. After filtration, the count was 0.152±0.01 x 10
9/L.
More than 97% of leucocytes were removed from the residual blood in the leucocyte-
depletion group. The average platelet count from the machine blood before filtration
was 107±6 x 10
9/L, after filtration, it was 43±2 x 10
9/L. About 60% of the platelets in
the machine blood were removed by the filters in the leucocyte-depletion group.￿
6
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Circulating leucocytes and platelets
Circulating leucocyte and granulocyte counts at the end of operation were
significantly less in the leucocyte-depletion group than in the control group (p < 0.05).
There were no significant differences in circulating lymphocyte and platelet counts
between the two groups (figure 1).
Inflammatory mediators
Thromboxane B2 levels were significantly lower in the leucocyte-depletion group
than in the control group at the end of operation (p < 0.05; table 2). Interleukin-6
levels increased in both the leucocyte-depletion and control groups during the early
postoperative period. No significant difference was found between the two groups.
Interleukin-2 was not detectable in any of the samples.
Lung function
Pulmonary gas exchange, measured by partial oxygen pressure, was significantly
higher in the leucocyte-depletion group than that in the control group both at one hour
after arrival in the intensive care unit (118 ± 10 mmHg versus 86 ± 10 mmHg, p <
0.05) and immediately after extubation (120 ± 8 mmHg versus 89 ± 10 mmHg, p <
0.05, figure 2). PAP was somewhat lower in patients receiving leucocyte depletion
than in the control group, but this difference in PAP was not significant. Similarly,
there were no statistical differences in PCWP and PVR between the two groups (table
3).
Other clinical outcomes
There was no significant difference between the two groups with respect to
postoperative blood loss recorded from the chest drainage until the first postoperative
morning. Duration of intubation after operation was slightly shorter in the leucocyte-
depletion group than in the control group, but this difference was not statistically
significant. Similarly, no statistical difference was found between the two groups
regarding the duration of intensive care unit and hospital stay (table 4).
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DISCUSSION
Leucocyte depletion from systemic circulation during cardiopulmonary bypass
has been reported to reduce free radical-mediated lung injury and granulocyte-
mediated ventricular dysfunction in animal experiments.
12-14 Clinically, however,
leucocyte depletion using an arterial line filter at the beginning of CPB has not
achieved the goals of reducing intraoperative and postoperative leucocytosis and of
improving lung function after heart operations.
15-19 In this study, we have
demonstrated that leucocyte depletion of only 1.2 to 2.1 litres residual heart-lung
machine blood significantly attenuates postoperative leucocytosis and improves
pulmonary gas exchange function in patients undergoing heart operations. Of more
importance, because this blood is usually transfused through the venous line without
any substantial filtration, leucocyte depletion in this setting may have provided a local
protective effect for the lungs, even if the amount is relatively small.
There are at least two reasons why leucocyte depletion of the residual heart-lung
machine blood may protect the lung. First, we observed in a recent study
22 that the
residual heart-lung machine blood contained higher levels of leucocyte release
products than seen in the systemic circulation, suggesting that the leucocytes
remaining in the heart-lung machine are highly activated. Second, it is known that the
heart-lung machine blood contains a number of foreign substances as well as
microaggregates formed mainly by platelets and leucocytes.
23,24 During CPB, the
blood is returned to patients from the arterial side of the heart-lung machine, where an
arterial line filter removes microaggregates. After CPB, however, the residual heart-
lung machine blood is reinfused to patients via intravenous transfusion without any
substantial filtration (usually only a clot filter with large pore size is used). Because
the lung is anatomically located to receive all the reinfused blood from venous side,
lung injury may occur as a result of the pulmonary accumulation of micro-
aggregates
25,26 mediated by trapped platelets and leucocytes.
In fact, current leucocyte-depleting filters remove not only leucocytes but also
other particulates less than 5 µm in diameter. It has been reported recently that a
similar type of blood transfusion filter was able to remove the microfibrillar collagen
haemostat from the wound blood harvested from the surgical field.
27 Particulate
microaggregates are continuously generated during CPB; this is particularly evident in
the cardiotomy returning line.
23 These microaggregates are mostly smaller than 30 µm
in diameter
23 and are not always caught by the cardiotomy filter which usually has a
pore size between 20 to 40 µm.
28 Because the residual machine blood collected at the
end of CPB contains a large portion of blood from the cardiotomy reservoir, filtration
with a leucocyte-removal filter may prevent any particulates larger than 5 µm from
being retransfused to patient, thereby reducing lung injury.
Although a direct comparison of our results with results obtained from arterial
line leucocyte depletion is unjustified, it does appear that leucocyte depletion of the
residual machine blood is more likely to have a local effect on protecting the lungs. In
addition, leucocyte depletion with transfusion filters may have other advantages in
clinical application. The procedure is easy to handle because the filter can be installed
at any time before use without flush or priming. Moreover, it could serve as an
optional intervention method that can be added at the end of CPB according to
patient’s clinical condition, particularly for patients with a longer duration of CPB and
a predicted strong postoperative inflammatory response. One potential disadvantageı
$
￿
of this method, however, is the limited blood volume available for filtration, which
depends on the volume of residual blood in the heart-lung machine.
The inflammatory mediator thromboxane B2 is usually increased during and after
CPB in patients undergoing heart operations.
29 In this study, we observed a
significantly reduction of plasma thromboxane B2 at the end of operation in the
leucocyte depletion group compared with the control group; this difference can be
explained by the removal of activated leucocytes and the simultaneous removal of
platelets after the end of CPB. We also measured interleukin-6 and interleukin-2; the
former is a marker of acute-phase response produced by mononuclear phagocytes and
the latter is mainly produced by lymphocytes.
30 We confirmed that the peak release of
interleukin-6 occurred about 1 hour after arrival in the intensive care unit, as reported
by other groups.
31 No significant difference was found between the depletion and the
control groups, however, which suggest that leucocyte depletion in this setting has no
effect on the release of interleukin-6 during the early postoperative period.
Interleukin-2 was not detectable in any samples, indicating that there was no
lymphocyte-associated release of cytokines in these patients. This is in agreement
with a recent report that interleukin-2 could be detected only occasionally after heart
operations.
32
One of the concerns regarding leucocyte depletion during heart operations is that
the simultaneous removal of platelets
13,17 might affect postoperative haemostasis. In
this study, little influence on circulating platelet count was observed in patients
receiving leucocyte depletion, although considerable numbers of platelets were
removed from the reinfused heart-lung machine blood. Consistently, there was no
significant difference between the two groups with respect to the postoperative blood
loss. On the other hand, it remains to be elucidated whether removal of platelets from
the residual heart-lung machine blood contributed to improved postoperative lung
function. It is known that the platelets may deposit in the myocardium during
reperfusion,
33,34 leading to myocardial reperfusion injury.
35 Moreover, release
products from platelets such as platelet activating factor and platelet associated
adhesive molecules may further activate leucocytes and promote leucocyte adhesion
to the endothelium.
36-38 This mechanism may also operate in initiating lung injury
because platelet deposition occurred similarly during lung reperfusion in the lung
microvasculature.
39
In conclusion, leucocyte depletion from residual heart-lung machine blood at the
end of CPB improves postoperative lung gas exchange function and reduces
postoperative leucocytosis. Furthermore, leucocyte depletion in this setting did not
result in any postoperative complications with respect to haemostasis and infection.
Further investigations should be carried out to compare the different leucocyte
depletion methods with respect to their clinical benefits against costs, and to
determine which patient populations can profit most from this intervention.
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CHAPTER 3
LEUCOCYTE FILTRATION OF RESIDUAL HEART LUNG MACHINE
BLOOD IN CHILDREN UNDERGOING CONGENITAL HEART SURGERY
A. J. de Vries, Y. J. Gu, W. van Oeveren
Perfusion 2004 ;19 :345-349￿
￿
￿
ABSTRACT
Cardiopulmonary bypass (CPB) leads to a generalized inflammatory reaction,
resulting in increased postoperative leucocyte counts and decreased pulmonary
function. In adults, removal of leucocytes from the residual heart-lung machine blood
after CPB improved postoperative oxygenation. In children, however, the clinical
effects of leucocyte filtration of the residual heart-lung machine blood are unknown.
Therefore, we measured postoperative leucocyte counts and arterial blood oxygenation
in children undergoing congenital cardiac surgery in a randomized prospective study.
Anaesthesia and CPB were standardized. After CPB, the residual heart-lung machine
blood was collected as usual. In a group of 25 children, this blood was filtered with a
leucocyte depletion filter before transfusion. A control group of 25 children received
this blood unfiltered. We found that the postoperative leucocyte counts were
significantly lower in the filter group than in the control group (p = 0.02, repeated
measurements ANOVA). This difference reached a maximum on the second
postoperative day (12.9 x 10
9/L filter vs. 15.9x10
9/L control, p = 0.02, Student’s t-
test). Values for the arterial blood oxygenation on the first postoperative day were not
different between both groups (15.5 ± 1 kPa filter vs.14.6 ± 1.3 kPa control, p = 0.57,
Student’s t-test). We conclude that leucocyte filtration of the residual heart lung
machine blood reduced systemic leucocyte counts, but did not improve arterial blood
oxygenation in children after congenital heart surgery.￿
￿
￿
INTRODUCTION
Cardiopulmonary bypass (CPB) leads to a systemic inflammatory reaction mainly
through activation of complement and leucocytes, resulting in increased postoperative
leucocyte counts and a decreased pulmonary function.
1-3 In children, the inflammatory
response to CPB tends to be more intense than in adults, because the surface of the
CPB circuit in relation to the total body volume is larger.
4 Moreover, this leucocyte-
mediated inflammatory response initiated during CPB is likely to have a significant
clinical inpact, as a negative correlation between the expression of leucocyte adhesion
molecules and postoperative oxygenation has been demonstrated recently in children.
5
Leucocyte filtration is a recently introduced technique to reduce a CPB-induced
inflammatory response.
6,7 Previously, we have shown in adults that leucofiltration of
the residual heart-lung machine blood after CPB resulted in a reduced inflammatory
response and improved lung function.
8 In this study we examined the effect of
leucofiltration of residual heart-lung machine blood on postoperative oxygenation and
circulating leucocyte counts in children undergoing congenital heart surgery.
METHODS
After ethical committee approval and parent consent, 50 consecutive children who
underwent congenital open-heart surgery were randomly divided into two groups.
Procedures selected were correction for tetralogy of Fallot, simple closure of a
ventricular septal defect, correction of atrioventricular septal defect, arterial switch
operation for transposition of the great arteries and completion of the Fontan
procedure. The power calculation for this study was based on the results of the partial
oxygen pressure of the arterial blood (PaO2) in our study in adults.
8 The PaO2 on the
first postoperative day was the primary end point for this study. It was therefore
estimated that with an a 0.05 and a b of 0.8, a total of 45 patients would be required to
reach a statistically significant difference. Thus, in 25 children, the residual blood from
the heart-lung machine after CPB was filtered with a leucocyte depletion filter before
retransfusion. In a control group of 25 children this residual blood was retransfused
unfiltered.
Anaesthesia was standardized and consisted of a midazolam and sufentanil
infusion. Pancuroniumbromide was used for muscle relaxation. Ventilation was aimed
at normocapnia with oxygen in air (FiO2 = 0.4), a tidal volume of 6-10 ml.kg
-1 and a
positive end-expiratory pressure of 2-4 cmH2O. CPB was instituted after heparin (300
IU/kg
-1) was given. The bypass circuit consisted of a double head roller pump
(Stöckert, München, Germany) and a hollow fibre oxygenator (Dideco safe micro or
Dideco 902, Sorin, Mirandola, Italy, depending on the size of the child). The flow
during CPB was 2.4 L/m
2 with moderate hypothermia (± 30
oC). The priming solution
consisted of human albumin 5% with 1000 IU heparin. If the calculated haemoglobin
on bypass was less than 4.5 mmol/L, packed cells were added to the priming solution.
After CPB and disconnection of the system, the residual blood in the heart-lung
machine was collected in a transfusion bag, and retransfused in the child during wound
closure and the first 2 hours in the intensive care unit (ICU). In the filter group this
blood was filtered with one leucocyte depletion filter (Pall RS 1, Pall, Portsmouth,￿
￿
￿
GB) for each patient. Other filtration procedures (e.g. modified ultrafiltration) were not
used.
We made the following measurements in the children. Leucocyte counts were
performed after induction of anaesthesia and on the first four postoperative days.
Platelet counts and the PaO2 were determined after induction of anaesthesia, after
arrival in the ICU and on the first postoperative day. In 10 children additional blood
samples were taken from the residual heart-lung machine blood. In these samples
leucocyte and platelet counts, and levels of haemoglobin and elastase, as a measure of
leucocyte activation, were determined.
The statistical analysis was done as follows. For comparison of single data
between the groups a two tailed Student’s t-test or the non-parametric Mann-Whitney
test was used as appropiate. For the comparison of the groups for oxygenation, platelet
and leucocyte counts on the different time points two way analysis of variance
(ANOVA) for repeated measures was used to identify time, group and time-group
interactions. To allow for multiple comparisons the Bonferroni adjustment was
applied. Values are given as mean and standard error of the mean for normal
distributed data, otherwise the median value and the 25 and 75 percentiles are given. A
p-value  0.05 was considered significant.
RESULTS
The demographic data were similar in both groups (table 1). Intraoperatively, 270
± 27 mL of residual heart-lung machine blood was collected in a transfusion bag after
CPB. This corresponded with an index of 707 ± 50 mL/m
2. The composition of the
residual heart-lung machine blood is shown in table 2.
The postoperative leucocyte counts increased over time (p < 0.001, figure 1), with
a significant difference between the filter and the control group (p = 0.02). Post-
operative platelet counts were not different between the groups (p = 0.11, repeated
measurements ANOVA, table 3).
The PaO2 values were similar in both groups (p = 0.43, repeated measurements
ANOVA, table 3). However, to investigate if the underlying disease of the children
influenced the postoperative PaO2 values, we divided the children in a subgroup with a
preoperative PaO2 = <8.4 kPa and in a subgroup with a PaO2 > 8.4 kPa. This arbitrary
value parallelled the division in underlying cyanotic and non-cyanotic disease. The
results, shown in table 4, indicate that in the cyanotic group (n = 28) the children in the
filter and the control group had a similar postoperative PaO2, whereas in the non-
cyanotic group (n = 22) the children in the filter group had a slightly higher post-
operative PaO2.
The haemodynamic data at the end of the operation were not different (table 3).
However to achieve that result dopamin (5-10 mg/kg/min) was used in 21 children in
the control group vs. 11 in the filter group (p = 0.004) and isoprenalin (0.01-0.02
mg/kg/min) was used in 11 children in the control group vs. 2 in the filter group (p =
0.004). Blood loss during the first 24 hours was not different (table 3).￿
￿
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Table 1. Demographic data
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DISCUSSION
Although the leucocyte depletion technology during cardiac surgery has repeatedly
been reported in adults, only limited information is available in children.
9-12 This study
shows that in children undergoing cardiac surgery leucofiltration of residual heart-lung
machine blood resulted in a prolonged reduction of postoperative leucocyte counts.
However, in contrast to adult patients, this did not result in a difference in
postoperative PaO2.
There are at least two possible explanations for the difference between adults and
children regarding the clinical effects. In the first place, we found high elastase values
in the residual blood, which were about twice the values that we previously found in
the residual heart-lung machine blood in adult patients.
13 The elastase values reflect￿
~
￿
the degranulation of leucocytes and are associated with tissue injury. Thus, although
the number of leucocytes in the residual blood is somewhat lower than in adults,
13 it is
likely that, after CPB, children have more activated leucocytes. Moreover, an increase
in leucocyte adhesion molecules has been demonstrated in children from the first to the
second postoperative day together with an increase in neutrophil counts, opposed to a
decrease in adhesion molecules and neutrophil counts in adults.
14 This could explain
why we found a more prolonged effect of leucofiltration on leucocyte counts in
children than in adults, where the leucocyte counts on the first postoperative day were
similar in the filter group and in the control group.
8 Second, the moment, or timing, of
leucocyte filtration during the operation may also play an important role in its clinical
significance and this could explain why we did not find an improvement in PaO2.
Children, especially children with cyanotic heart diseases have a low tolerance for free
oxygen radicals, and it is therefore likely that the damaging effects of activated
leucocytes occur in the initial reperfusion phase, immediately after aortic cross-clamp
release.
9 This has also been shown as an increase in myeloperoxidase and lactoferrin,
as markers for leucocyte activation, immediately after aortic cross clamp release.
15
Thus in the cildren in the cyanotic group, with the large difference in pre- and
postoperative PaO2 values, leucofiltration of the residual heart-lung machine blood
was too late to have an effect, which may explain why the postoperative PaO2 values
in the filter and the control group were similar. In contrast, the children in the non-
cyanotic group, with no difference in pre- and postoperative PaO2 values, had no
oxygen stress and thus in this small subgroup statistical significance in the
postoperative PaO2 values between the filter and the control group was nearly
obtained. Currently, leucocyte depletion filters suitable for use in a paediatric
extracorporeal circuit are not available, which prevents earlier use of leucofiltration
during the operation. A paediatric arterial-line filter has been used, but was withdrawn
due to reported clotting in the CPB circuit distal to the filter
10. Thus, our strategy for
children may be too late for an effect on oxygenation, but sufficient for an effect on
leucocyte counts.
Although platelets are removed by leucocyte depletion filters,
16 there was no
significant difference between the two groups regarding the postoperative platelet
counts. This finding may also explain that the postoperative blood loss was not
different between the two groups. The amount of retransfused residual blood in the
children, indexed on body surface, was comparable to that in the adult patients.
8 We
transfused this blood during wound closure and the first 2 hours in the ICU. This was
not due to a flow limitation in the filter, but to the capacity of the child to accept the
transfused volume. For each patient we used one filter, which costs about 30 euro.
However, a larger study is necessary to assess if the use of these filters is cost-
effective.
An unexpected finding was that more inotropes were used in the control group.
This was transient, because on the first postoperative day this difference was not
present. Reduced inotropic support after leucofiltration has been described
previously.
12,17 Our results support these findings and suggest that even leucofiltration
performed shortly after CPB results in a more stable haemodynamic profile.
Our study may be limited by the fact that we did not measure biochemical
parameters such as elastase or interleukins in the children. The measurement of
biochemical parameters would, of course, be helpful to gain insight in the effects of￿
]
￿
leucocyte depletion, but, for the widespread application of a filtration strategy, it is
necessary to obtain clinically useful results, which was on our primary clinical
endpoint, an improved postoperative PaO2 in the filter group, not the case in this study.
A second limitation is the heterogenous patient group. We tried to minimise this by the
selection of well described disease entities, and by a post hoc analysis of the effects of
leucofiltration in cyanotic and non-cyanotic children. However, the pre- and
postoperative PaO2 should be interpreted with caution.
In conclusion, we found a significant reduction in leucocyte counts in children
after corrective surgery for congenital heart disease by the transfusion of leucocyte
depleted residual heart-lung machine blood. However, we did not find significant
effects on postoperative oxygenation. Since the elastase levels in the residual heart-
lung machine blood are high, and there is currently no suitable paediatric arterial in-
line filter to achieve leucocyte depletion during CPB, the removal of leucocytes from
this blood may offer an alternative to reduce the inflammatory reaction in children
after congenital heart surgery.
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CHAPTER 4
FILTRATION OF ACTIVATED GRANULOCYTES DURING
CARDIOPULMONARY BYPASS SURGERY:
A MORPHOLOGIC AND IMMUNOLOGIC STUDY TO CHARACTERIZE
THE TRAPPED LEUCOCYTES.
J.J.J. Smit, A.J. de Vries, Y.J. Gu, W. van Oeveren
The Journal of Laboratory and Clinical Medicine 2000,135:238-245¥
/
ƒ
ABSTRACT
Cardiopulmonary bypass surgery induces an inflammatory reaction among others by
granulocytes. Leucocyte filtration has been shown to reduce the postoperative morbidity
mediated by activated granulocytes. However, little is known about the mechanism of
filter-leucocyte interaction. This study examines whether a leucocyte filter removes
activated granulocytes or a general leucocyte population.
Eleven patients undergoing cardiopulmonary bypass surgery were included in this
study. Leucocyte filtration was achieved before the reperfusion phase with a Pall non-
woven polyester filter located at the venous side of the heart-lung machine. After
filtration, the trapped granulocytes inside the filter were examined with light and
scanning electron microscopy and immunologically by CD45RO antigen binding to the
filter material. Furthermore, leucocyte release markers were measured to determine
whether cells were activated during filtration.
On microscopic evaluation it was found that 84% granulocytes and 14%
lymphocytes were trapped in the filter, compared with 78% granulocytes and 22%
lymphocytes in the blood before filtration. Granulocytes were trapped significantly more
in the first blood contact layer of the filter material than in the middle layer and last layer,
whereas lymphocytes trapped slightly more in the middle layer. The near maximum level
of CD45RO expression was measured on granulocytes trapped inside the filter material,
whereas CD2 and CD19 measured on lymphocytes were bound to a minor extend. ß-
Glucuronidase concentration did not increase after filtration, suggesting the absence of
activation of granulocytes by filtration.
The results of this study suggest that a leucocyte filter made of non-woven polyester
material removes the activated granulocytes rather than leucocytes at random. This
implies that this particular type of leucocyte removal filter is suitable for use in
cardiopulmonary bypass patients whose granulocytes in the circulation are activated.
Furthermore, measurement of activated granulocytes instead of total leucocyte count is
likely preferable for functional assessment of leucocyte removal devices.§
[
¤
INTRODUCTION
Foreign materials used in the Cardiopulmonary bypass (CPB) circuit during heart
surgery activate leucocytes, resulting in increased cell adhesiveness, release of oxygen
radicals and enzymes, and finally, damage to the host.
1-9 Primarily the neutrophilic
granulocyte fraction is activated after initial contact with extracorporeal surfaces.
3-7 It has
been suggested that removal of these activated granulocytes by filtration reduces
morbidity after heart surgery.
10-15 However, during leucocyte filtration in CPB
procedures, we observed a large patient-related variation in filtration efficiency.
16 Based
on the suggested mechanism of leucocyte removal by synthetic filters – that is, by
adhesion to the filter material rather than by seaving
17 – we speculated that this variation
in filtration efficiency was related to a difference in the expression of leucocyte receptors,
leading to a difference in adhesion capacity to the filter material. However, it has never
been reported, by directly studying the leucocyte-filter interaction, whether during CPB,
leucocyte filters remove granulocytes at random or remove primarily an activated subset
of granulocytes. Therefore, we designed this study to examine whether leucocyte filters
remove a large portion of activated granulocytes or a general leucocyte population. To
achieve this goal, we used a filter during 14 minutes in the clinical setting of CPB and
performed electronic cell count and biochemical tests on blood samples taken before and
after filtration. Additionally, we performed histologic examination on embedded filter
material and immunologic tests to show the presence of ‘activation receptors’ on
leucocytes trapped inside the filter and on whole blood samples before and after
filtration.
METHODS
Patients
After approval was received from the ethical committee and informed consent was
received from patients, 11 patients undergoing an elective heart operation for either
coronary artery bypass grafting or heart valve replacement were included in the study.
Exclusion criteria were a history of allergy or recurrent infection, reoperation, and
emergency operation. The characteristics of the patients are summarized in table 1.
Heart operation procedure
Anaesthesia was induced and maintained by intravenous infusion of sufentanil
citrate (1 to 3 mg/kg) and midazolam (0.05 to 0.1 mg/kg). Muscle relaxation was
achieved with pancuronium bromide (0.1 mg/kg). Cefamandol at a dose of 2 g and
dexamethasone at a dose of 1 mg/kg were administered after induction. Anticoagulation
was achieved by intravenous administration of bovine lung heparin at a dose of 300
IU/kg approximately 5 minutes before the start of CPB. Anticoagulation was monitored
by Celite activated clotting time (International Technidyne Co, Edison, NJ). After CPB,
heparin was neutralized by protamine chloride (3 mg/kg). The heart-lung machine
consisted of roller pumps (Stöckert Instrumente GMBH, Munich, Germany) and a
microporous polypropylene membrane oxygenator (CML Excel; Cobe Laboratories Inc.,
Lakewood, CO).  Within 10 minutes of CPB initiation at a flow rate at 2.4 L/min/m
2, the'
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aorta was cross-clamped and 1 L St. Thomas cardioplegic solution (4
oC)  was  infused
into the aortic root  to provide myocardial preservation. During CPB, moderate
hypothermia was induced (table 1). The mean arterial pressure was maintained at 50 to
60 mmHg during CPB.
Leucocyte filtration
Leucocyte filtration was achieved by using a prototype leucocyte removal filter (B
1320A; Pall Biomedical, Portsmouth, England). This was a redesign of the prototype
filter used for our previous study
16 to make it easier for clinical handling. The filter was
incorporated in the circulation, in a parallel circuit at the venous site of the heart-lung
machine, and one of the roller pumps (Stöckert) was used to maintain a flow rate of 500
mL/min. Leucocyte filtration was performed during the rewarming phase at the end of
CPB just before release of the aortic cross-clamp and lasted for approximately 14
minutes. During filtration the pressure at the inlet side of the filter averaged 74 ± 17.5
mmHg.
Blood sampling
Blood samples were taken before and after filtration from the radial artery of the
patients and every 2 minutes during filtration from the inlet and outlet sides of the filter.
The blood specimens were collected in sodium citrate (0.32%). Leucocyte counts were
performed with an electronic cell counter (Cell-Dyn 610; Abbott, Santa Clara, CA) to
asses leucocyte removal by the filter. The relative cell removal rate was calculated every
2 minutes according to the following formula: relative cell removal rate = (1-[post-filter
count/pre-filter count]) x 100. The average cell removal was calculated as a mean of the
relative removal rates. The total number of removed cells was calculated by multiplying
of the absolute number of removed cells per liter (post filter count minus pre-filter count)
with the volume of filtered blood. For biochemical assays, plasma was obtained by
centrifuging of whole blood at 4°C for 10 minutes at 1100g, whereafter plasma was
stored at -80°C until further examination. ß-glucuronidase, a release product of activated
granulocytes, was determined by an enzymatic assay (photospectrometry; Boehringer,g
i
h
Mannhein, Germany) in plasma samples from the inlet and outlet sides of the filter, after
8 minutes of filtration, to indicate activation of granulocytes by the filter material.
Platelet activating factors inhibiting capacity (PAF-IC) was also determined from the
inlet and outlet sides of the filter after 2 minutes filtration by turbidometry in an
aggregometer (Chrono-Log, Havertown, PA) to indicate platelet activating factor (PAF)
production by activated leucocytes. The measurement of PAF-IC was conducted with
platelets isolated from citrated platelet-rich plasma containing indomethacin (50 mg/mL)
from the blood of a healthy volunteer by filtration through Sepharose CL-2B (Pharmacia
Biotech Inc., Stockholm, Sweden). These platelets were resuspended in saline to a final
platelet concentration of 50 x 10
9/L and added to the plasma of the study patients. The
maximum velocity of platelet aggregation was measured after PAF C16 (Cayman
Chemical, Ann Arbor, MI) addition and was used to indicate the PAF-IC of the patients’
samples. Because the PAF-IC is maximal in normal plasma and reduces after PAF
formation, normal human plasma was used as a negative control and saline as a positive
control, resulting in no aggregation of the platelets and maximum aggregation of the
platelets, respectively.
Morphologic examination of leucocyte entrapment
Nine leucocyte filters were collected immediately after CPB and were prepared for
histological examination to enable differential leucocyte counting in the cross-section of
the filter material. After release of the residual blood, the filters were perfused in their
indicated flow direction with 500 mL of normal saline solution under a consstant
pressure of 75 mmHg to wash away the unbound leucocytes. This low perfusion pressure
did not exceed the clinical filtration pressure and was chosen to prevent the release of
attached leucocytes by high shear forces. To further control the stability of leucocyte
binding within the filter, part of the filter material was washed again after the standard
procedure with 3 L of normal saline solution under similar perfusion pressure. In each
filter, leucocytes were counted in 3 different layers of the cross-section. This comparison
showed that washing the filter with 500 mL of normal saline solution did not differ
significantly with results when washing with 3 L of saline solution in regard to bound
leucocytes (table 2) and thus was used as a standard procedure for the future
experiments. After washing, the filters were cut open without damaging the filter
material, and within 60 minutes after filtration, partly fixated in 4% paraformaldehyde
0.1 mol/L phosphate buffer (pH 7.4) and stored at -20°C. In duplicate, samples of the
fixed filter material were dehydrated with alcohol and distilled water and embedded in
plastic (GMA, Technovit 8100). Series of three slices of 2 mm were cut out of the cross-
section of both samples of the plasticized filter material with a microtome (Jung 1140)
and a D-knife with a Tungsten Carbide edge (16/20). Thus in total, 6 samples of each
filter were prepared for light microscopy. All slices were stained by standard histologic
methods with May-Grunwald-Giemsa and viewed under the microscope. Leucocytes in
each slice were counted on three locations of the cross-section of the filter material. As
the first location, the first layer of the filter material touched by blood was chosen. As the
second location, the middle layer of the cross-section was viewed. As the third location,
a microscopic view of the last layer, which bordered on the outlet of blood from the
filter,  was  examined.  Differential  counting  for  segmented  neutrophilic  granulocytes,j
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9
band neutrophilic granulocytes, lymphocytes, monocytes, eosinophilic and basophilic
granulocytes was done in one microscopical field (enlargement x400) under the
condition that at least 100 cells were counted in one layer. For scanning electron
microscopy, pieces of filter material out of the same three layers that had been fixed were
used. Postfixation was performed with 1% OsO4 in phosphate-buffered saline solution
for 3 hours, followed by dehydration in ethanol series. After critical point drying with
CO2, the samples were supercoated with gold and examined with scanning electron
microscopy at 2 kV (Jeol 6301F, Tokyo, Japan).
Immunologic examination of activated granulocyte entrapment
The freezer-stored non-fixed parts of the filters were examined for the binding of
specific antibodies to cells trapped inside the filter material. The antibodies used for this
procedure were labeled with europium Eu-DDTA (Wallac, Turku, Finland), which
allows sensitive detection by means of time-resolved fluorescence.
18 Mouse anti-human
CD45RO monoclonal antibody (Caltag Laboratories, San Francisco, CA) was used as a
marker for the specific binding of activated granulocytes. To estimate the amount of
CD45RO binding to T and B cells, specific antibodies against T-cell receptors (mouse
anti-human CD2 monoclonal antibody; Caltag Laboratories) and against B-cell receptors
(mouse anti-human CD19 monoclonal antibody; Caltag Laboratories) were used. To
measure the binding of the antibody to the cells trapped inside the filter material,
materials were separated in three layers representing the same specific locations of the
cross-section of the filter material used in the morphologic examination. Each layer was
divided into three parts. This resulted in nine parts per filter to be tested. Each part was
carefully weighed to correct the amount of antibody binding for filter mass. Then,
through a standard procedure, each part was washed with saline solution and incubated
for 30 minutes with Eu-labeled antibody on a plateshaker and for 5 minutes with 3%
H2O2. After the non-bound antibody was washed away, the Eu was released in
enhancement fluid and counted in an Arcus (Wallac). A negative reference was made
during each test by triplicate measurement of the nonspecific antibody binding to a
sample of non-used filter material that had been incubated for 60 minutes in leucocyte-;
4
<
and platelet-free plasma. A positive reference was made on filter material samples from 3
patients to test the maximum CD45RO binding to the filter material; Zymosan-activated
plasma (Sigma, St. Louis, MO) containing high concentrations of C5a was incubated
with the filter material for 20 minutes before CD45RO antibody binding.
19,20
In addition, removal of activated leucocytes from the blood of patients during CPB
was tested by flow cytometric measurement of the adhesive receptor present on activated
granulocytes (CD11b; DPC, Los Angeles, CA) in blood before and after the filter. Thus
from 3 patients, blood samples were taken before filtration from the radial artery, before
and after passing the filter at 2 and 10 minutes filtration from the afferent and efferent
lines of the filter, and after the filtration procedure from the radial artery. Immediately
after collection in sodium citrate (0.32%) blood was incubated with phyco-erythrin-
labeled anti-CD11b, treated with Optilyse C (Immunotech, Marseilles, France), and
prepared for flowcytometric analysis (FACS, Coulter, Luton, England).
Statistics
Before data analysis, all non-categorical data were tested and found normal
distributed according to the Kolmogorov-Smirnov goodness-of-fit test. An unpaired two-
tailed Student t test was used to test the differences between the different leucocyte
counts, non-categorical patient characteristics and immunologic data. An unpaired one
tailed Student t test was used to test the difference between the rinsed and extra-rinsed
microscopical leucocyte counts. To detect possible differences between microscopic cell
counts in the three different layers in cross-section, one way analysis of variance was
used to compare groups. Duncan’s multiple comparison post hoc procedure was used to
quantify any differences among groups that were found to be significant. A value of p <
0.05 was considered statistically significant. All haematologic, morphologic,
immunologic and biochemical data are expressed as mean and standard error of the
mean, unless otherwise indicated.
RESULTS
Morphologic examination of leucocyte entrapment
Under light microscopy, the number of segmented neutrophilic granulocytes, band
neutrophils, monocytes and eosinophilic and basophilic granulocytes was significantly
reduced along the flow direction through the three layers of the cross-section of the filter
material (table 3).
The middle and last blood contact layer showed statistically significantly fewer
granulocytes than the first layer (p < 0.0001). Lymphocyte counts, however, did not
differ significantly between the first two layers but were significantly reduced in the last
layer (table 3).  In total over 3 layers, granulocytes comprised 84% of the total
microscopically counted leucocytes. Lymphocytes attributed 14% to the total counted
leucocytes. The electronically measured composition of leucocytes in blood before
filtration was 78% granulocytes and 22% lymphocytes. Massive adhesion of
granulocytes to the filter material was also shown by scanning electron microscopical
pictures of the filter material after use in the clinic (figure 1). Additional electronic
leucocyte  counting  in  blood  revealed  an average leucocyte removal during the first 10=
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minutes of filtration of 79% (table 4). Granulocyte removal was 84% and lymphocyte
removal 73% (table 4). In five sequential measurements during the first 10 minutes a
gradual decrease of leucocyte removal, from 91% to 70% (table 4), was observed.
However, in spite of 10 minutes leucocyte filtration, the average systemic leucocyte
counts measured in 11 patients did not change during the period of filtration (before
filtration 3.68  ±  0.42, after filtration 3.62  ±  0.49; p-value 0.94).
Immunologic examination of activated granulocyte entrapment
A significant increase in CD45RO binding to the filter material after leucocyte
filtration in comparison with the non-specific binding without leucocytes was found
(P<0.001, figure 2). In the middle layer no increase was found in the CD45RO
expression after further stimulation of granulocytes with Zymosan-activated plasma
(figure 2). In the first and last layers, however, CD45RO expression increased after
Zymosan stimulation (figure 2). Microscopic granulocyte count, CD45RO binding, and
maximal CD45RO binding to the filter decreased significantly along the flow direction.
Proving the validity of the test, the decrease of microscopical granulocyte counts
correlated best with the decrease in maximal CD45RO expression. A significant CD2
binding (T cells) to the three different filter layers as compared with the non-specific
binding was discovered. CD19 binding (B cells), however, was significantly different
only from the non-specific binding in the middle layer. The average CD2 binding was, in
accordance to the microscopic lymphocyte count, highest in the middle layer, although
no significant difference was found between the layers (figure 3).
The additional antibody tests by means of flowcytometric assessment on whole
blood samples showed a clearly detectable CD11b expression in blood before filtration,
whereas  after  filtration  the  CD11b  expression  was  below  the   detection   limit.   The￿
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removal of CD11b expressing cells, however, did not result in a significant reduction of
the CD11b expression of leucocytes remaining in the systemic circulation after filtration.
The background count, measured by a control antibody remained during the whole
procedure less than 4% of the initial count before filtration.
Other biochemical measurements in blood samples
ß-glucuronidase, measured in 8 patients, was 0.17 ± 0.02 before the filter and 0.17 ±
0.03 after the filter (p = 0.82), indicating no activation of granulocytes by the filter
material or of granulocytes attached to the filter material. Furthermore, PAF-IC was not
reduced after the filter as compared with before the filter.
DISCUSSION
The removal of leucocytes during CPB has been reported to reduce postoperative
complications after heart surgery.
12,13,21 It is not known, however, whether this reduction
is due to the removal of activated granulocytes or to at-random removal of leucocytes.
This study showed that the filter removed mainly the activated granulocytes, as indicated
by the following findings. First, CD45RO, a specific marker for activated granulocytes
showed a significant and almost maximum amount of binding to the filter material,
indicating that the majority of granulocytes trapped inside the filter material was
activated. Second, a nearly complete reduction of CD11b, another marker of activated
granulocytes, after the filter suggests the removal of activated granulocytes. Third, the
granulocyte portion of total leucocytes inside the filter material was 84%, as compared to
77% in blood before filtration. The lymphocyte portion inside the filter material was 14%
compared with 23% in the blood before filtration. Therefore the filter material trapped
primarily granulocytes rather than lymphocytes.
The enormous CD45RO binding to the filter material in the first layer, where 75%
of the granulocytes were trapped, was followed by a maximum CD45RO expression
level in the middle layer. However, CD45RO binding to the middle layer might have
been caused by the enhanced portion of lymphocytes. The last layer, in contrast,
functioned less efficiently in respect to the amount of bound cells and the activation
level. However, the CD45RO counts per granulocyte in the last layer were approximately
two times higher than those in the first layer. The amount of CD45RO binding in the last
layer might also have been enhanced by a relative increase in the percentage of
lymphocytes (38% in the last layer as compared with 6% in the first layer). Absolute or
relative enhancement by lymphocytes in the middle and last layer may therefore have
been the cause of the discrepancy between the microscopically counted granulocytes and
the CD45RO binding. The filter was composed of one layer that we artificially divided
into three layers. Eliminating the last blood contact layer may have reduced the loss of
lymphocytes. In patients undergoing CPB, lymphocytes are preferably preserved to
maintain the host defence mechanism. Clearly a less-solid structure of the filter material
would reduce the potential danger of flow obstruction by filter resistance. Even in a filter
with a large pore size such as the one we used (figure 1), the accumulation of leucocytes
might activate other blood elements, resulting in a cascade reaction that could obstruct
the filter and damage the blood. The release of PAF might play a crucial role in
activating platelets as the origin of a large clotting reaction.
22,23  PAF levels caused by˝
Y
˛
this filter, fortunately, were not enhanced after filtration. Also coagulation may be
enhanced by Factor X binding to CD11b, which is clearly expressed on the granulocytes
during CPB.
24
Although CD45RO was originally used for detecting 45% of T and a few B cells, it
was lately discovered that the antibody also binds to activated granulocytes.
25-29 Since the
filter material was especially designed for binding granulocytes, the expectation was that
CD45RO would primarily be a marker for activated granulocytes. Given the results of
the CD2, CD19 and microscopic leucocyte count in the filter material, it can also be
concluded that CD45RO primarily measured the binding of activated granulocytes. CD2
binding to the filter material was not extensive and did not significantly differ among the
three layers of the filter material. CD19, reflecting B cell binding did not even bind to the
first and last blood contact layer. CD45RO, on the contrary, bound massively in
accordance with the amount of microscopically counted granulocytes to the first layer
and decreased in average in the middle and last layers. Therefore it can be concluded that
this massive CD45RO binding to the first layer was at most 10% caused by the binding
of lymphocytes. Furthermore, CD45RO is thought to be suitable marker for activated
granulocytes, although this is not widely accepted.
The microscopic leucocyte counts of the filter material were also useful as controls
for the antibody tests. In support of the validity of the antibody tests, and the CD2 and
CD19 binding tests, the microscopical leucocyte counting tests showed a slight increased
average binding of lymphocytes to the middle layer of the filter material. In addition, at a
maximum CD45RO expression level of the granulocytes, Eu counts correlated perfectly
with the number of microscopically counted granulocytes.
The leucocyte removal rate from circulating blood declined from 90% to 70% at the
end of filtration, although large individual differences in the absolute numbers of
removed cells existed among the patients (4.2 to19.4 x 10
9 / 5 liters blood). Therefore it
is less likely that the filter lacked capacity for leucocyte adhesion; otherwise all patients
would have demonstrated a similar total amount of removed leucocytes. A more
plausible explanation would be the internalization of adhesion receptors by the filter
material after the first pass, resulting in a decreased adhesive capacity of leucocytes
contacting the filter material for the second time. The failure of leucocytes to adhere to
artificial surfaces when exposed to monoclonal antibodies against CD11b receptors has
been described.
30 Also, the internalization of CD11b receptors after exposure to various
stimuli has been reported.
31-33 Thus it might be more wise to enlarge the first contact
layer of leucocyte filters instead of the thickness of leucocyte filter material.
Although a considerable amount of activated granulocytes have been trapped in the
filter, the systemic granulocyte counts did not change during the period of filtration. This
is most likely due to the fact that the systemic rewarming of blood started in parallel with
leucocyte filtration, which means that a new population of granulocytes entered the blood
stream massively from the third space, extravascularly, and from the bone marrow. Other
evidence supporting leucocyte entry into the blood stream was the finding of level
amounts of granulocytes expressing CD11b in the pre-filter blood samples during the
whole period of filtration, in spite of a clear removal of CD11b expressing cells.
Actually, this newly released population of granulocytes in the circulation counteracts the
reduction effect made by leucocyte filtration. Indeed, the reduction of systemic
leucocytes by leucocyte filtration is obvious when compared with results in a group ofˇ
I
—
control patients whose increase in systemic leucocytes during the rewarming phase was
more severe than in filtration patients.
It seems that the adhesion of granulocytes to the filter material did not result in
further granulocyte activation, since there was no enhanced ß-glucuronidase, and PAF
from stored granules. It demonstrates that the cellular structure remains intact during the
relatively mild flow conditions in our venous bypass circuit.
In conclusion, we have shown that the activated part of the granulocytes and not
leucocytes at random are removed by the presented type of leucocyte filter. These
leucocyte removal filters may appear suitable for use in heart operation patients, whose
granulocytes in the circulation are activated. Individual differences in granulocyte
activation level might therefore be a plausible explanation for the large differences in
filtration efficiency between patients. Moreover, the measurement of activated
granulocytes instead of total leucocyte count might be preferable for assessment of
leucocyte filter devices in the future. Furthermore, this study shows that the filter likely
does not need a high capacity, since the activated granulocytes either adhere immediately
or do not adhere at all.  Finally, removal of activated granulocytes during CPB did not
alleviate the patient’s exposure to activated granulocytes, since the remaining
granulocytes and those from the marginating pool replaced the removed cells
immediately. Therefore, to reduce the post-perfusion syndrome, repeated leucocyte
filtration should be considered to enhance the efficiency of filtration.
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CHAPTER 5
LEUCOCYTE DEPLETION DURING CARDIAC SURGERY:
A COMPARISON OF DIFFERENT FILTRATION STRATEGIES.
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ABSTRACT
The results of leucocyte filtration during cardiac surgery are conflicting. This may
be due to timing and duration of the filtration procedure, and to flow and pressure
conditions in the filter. Therefore, we prospectively compared three major leucocyte
filtration strategies in cardiac surgical patients.
Forty patients were randomly divided into four groups. Group I: leucofiltration of
arterial blood throughout cardiopulmonary bypass (associated with high flow and
pressure gradients), group II: Leucofiltration of a part of the venous return blood in the
rewarming phase during cardiopulmonary bypass (associated with intermediate flow,
but high pressure), group III: Leucofiltration of residual heart-lung machine blood
during transfusion into the patient after cardiopulmonary bypass (associated with low
flow and low pressure), group IV: Control group without leucofiltration. We measured
circulating leucocyte counts, plasma elastase levels and arterial blood oxygenation.
Filters were postoperatively examined by scanning electronmicroscopy.
We found that leucocyte counts increased over time and oxygenation decreased in
all groups, without significant difference between the groups. Scanning electron-
microscopy demonstrated extensive protein deposits and damaged leucocytes in the
deeper layers of the filters from group I. This was not observed in the filters from
group III. The postoperative plasma elastase levels increased in group II and IV and
decreased in group I and III.
The results from this study did not demonstrate a clinical difference among the
three leucocyte depletion strategies. However, our laboratory results suggest that
leucocyte filtration at low flow and pressure conditions is associated with less
leucocyte damage and less release of elastase.￿
￿
￿
INTRODUCTION
Cardiopulmonary bypass (CPB) leads to a well known systemic inflammatory
response and contributes to postoperative morbidity and organ dysfunction.
1-3
Polymorphonuclear leucocytes and complement are activated as a result of blood
contact with the surface of the CPB-circuit and are considered as important causes for
organ dysfunction, notably of the lungs.
4-6 Leucocyte depletion by means of filtration
has been introduced into clinical practice to reduce this inflammatory response.
However, the reported clinical results of leucofiltration are conflicting. Some studies
demonstrate a reduction in leucocyte counts
7-13 and an improvement in ventilatory
parameters,
7-8 whereas others do not.
14-17 These differences may be caused by the
timing and duration of the filtration procedure during the operation, and the location of
the filter in the CPB circuit. For instance, filtration may be applied throughout
CPB,
7.10,13-15 or in short, but well aimed time spans;
9,12,16 on the arterial,
7,9,10,12-15 or
venous
11 side of the CPB circuit; or even outside the CPB circuit, as for filtration of
residual heart-lung machine blood.
8 In addition, these various filtration procedures are
associated with different flow and pressure conditions over the filter. Filters used
under high pressure and flow conditions (e.g. arterial line filters), may have other
characteristics of leucocyte entrapment than filters used under low pressure and flow
conditions (e.g. filters for residual heart-lung machine blood). It is not known how
these factors affect the filter efficiency.
Therefore, we compared in this study the clinical effects of leucofiltration via the
arterial line throughout CPB, leucofiltration via the venous line during rewarming and
leucofiltration of residual heart-lung machine blood after CPB. These are the three
major strategies for leucofiltration during cardiac surgery, each associated with a
different volume filtered and with different flow and pressure conditions. In an attempt
to study the effects of flow and pressure conditions during filtration, we also examined
filters after use with scanning electron microscopy (SEM).
MATERIALS AND METHODS
Patients and filtration procedures
After institutional human investigation committee approval and patient consent,
40 patients scheduled for elective coronary artery bypass grafting (CABG) or valve
replacement were randomly allocated to 4 groups of 10 patients each. Exclusion
criteria were pre-existing lung disease, emergency operation and re-operation. In group
I, leucofiltration was achieved throughout cardiopulmonary bypass (CPB), using a high
flow leucocyte removal filter (LG6, Pall Biomedical, Portsmouth, UK), incorporated in
the arterial line. This procedure was associated with high flow and pressure gradients
over the filter. In group II, leucofiltration of a part of the venous return blood was
achieved during CPB in the rewarming phase until aortic cross-clamp release, using
paired leucocyte removal filters (RS 1, Pall Biomedical, Portsmouth, UK) as
previously described.
11 Blood flow was adjusted with a separate roller pump to 400
mL/min. The filtration pressure, measured between the pump and the filter, was
generally high, ³ 150 mmHg, but did not exceed 300 mmHg. The filtration procedure￿
￿
￿
lasted 10 ± 0.7 min., and thus the amount filtered was 4000 ± 80 mL. This procedure
was associated with intermediate flow, but high pressures. In group III, leucofiltration
of the residual heart-lung machine blood (1.2 to 2 L) was achieved as it was transfused
into the patient after CPB, using a leucocyte removal filter (RS 1, Pall Biomedical,
Portsmouth, UK). The blood was transfused under gravity, £ 100 mmHg. This
procedure was associated with low flow and low pressures. In group IV, no
leucofiltration was applied. These patients served as controls.
Methods
Anaesthesia was induced and maintained by intravenous infusion of sufentanil (1
to 3 mg/kg) and midazolam (0.05 to 0.1 mg/kg). Pancuronium (0.1 mg/kg) was used
for muscle relaxation. Ventilatory management was aimed at normocapnia throughout
the operation and in the intensive care unit (ICU), with an inspiratory oxygen fraction
of 0.4, a positive end-expiratory pressure of 6-8 cm H2O and a tidal volume of 6-8
mL/kg. Dexamethasone (1 mg/kg) was administered after induction. Bovine lung
heparin (300 IU/kg) was used for anticoagulation. This was monitored by the celite
activated clotting time (International Technidyne Co., Edison, N.J., USA) and
maintained at a value of at least 400 s. After CPB, heparin was neutralized by
protamine (300 IU/kg).
The extracorporeal circuit consisted of roller pumps (Stöckert Istrumente GmbH,
München, Germany) and a membrane oxygenator (CML Excel, Cobe Laboratories,
Lakewood, CO, USA) primed with 500 mL hydroxyethylstarch 10% (Haes, Fresenius,
Bad Homburg, Germany) and 1500 mL lactated Ringer's solution. Arterial line filters,
other than the one studied, were not used. Flow rate was adjusted to 2.4 L/m
2/min.
Blood pressure during CPB was kept between 50 and 80 mmHg and nasopharyngeal
temperature was maintained at 30
oC. The surgical wound suction blood was returned
to the cardiotomy reservoir of the CPB circuit in all patients. Cell-savers were not
used. The residual heart-lung machine blood after CPB (± 1.3 L) was transfused into
the patients in all groups.
Scanning electronmicroscopy
Histological examination of the leucocyte filters by SEM was performed as
previously described.
18 Briefly, 3 filters in each group were after filtration rinsed with
500 mL normal saline by a roller pump at a flow rate of 100 mL/min. After rinsing
each filter was opened and two samples of the filter medium were taken. Each sample
was divided in three layers, a superficial layer where the blood entered the filter, a
middle layer and a deep layer where the blood left the filter. All samples were
immediately fixated in a 2% glutaraldehyde solution with 0.1 M cacodylate buffer at
pH 7.4. Further processing consisted of standard SEM preparation, including fixation
with 1% osmium-tetra-oxyde, dehydration in ethanol series, critical point drying and
gold sputter coating. The samples of the three layers were subsequently studied with
SEM (JEOL 6301F, Tokio, Japan) by two independent observers to obtain a
qualitative assessment of the filter characteristics.￿
￿
￿
Clinical Measurements
Blood samples for laboratory tests and biochemical assays were drawn from the
radial artery of the patient after induction of anaesthesia, at the end of the operation,
after 3 hours in the ICU and on the morning of the first postoperative day. The arterial
oxygen tension (PaO2) was measured and the alveolar-arterial (A-a) oxygen gradient
was calculated, using standard formulae. From EDTA-anticoagulated blood,
haematocrit and platelet, total white blood cell and granulocyte counts were
determined by an electronic cell counter (Cell-Dyn 610, Abbott, Santa Clara, CA,
USA). Plasma elastase, as marker of leucocyte activation, was determined using an
enzyme immunoassay (Merck, Darmstadt, Germany).
Perioperative fluid balance, use of inotropic agents, myocardial infarctions
(defined as new Q-wave on the ECG and CK > 180 U/L with CK-MB > 10% of total),
of postoperative intubation, and length of stay in the ICU and the hospital were
recorded from the patient charts. The attending ICU and hospital staff were blinded to
the study group.
Statistics
All data are presented uncorrected for haemodilution and expressed as mean ±
standard error, except for elastase for which percentages are used, because of a high
range of starting values. For comparison between the groups one way analysis of
variance (ANOVA) was used with a post-hoc analysis using the Bonferroni method
when necessary. To determine the effects of time and interaction between the groups
over the different time points repeated measurements ANOVA was used. To correct
for non-sphericity Greenhouse-Geisser (e) adjustments were made. A p-value £ 0.05
was considered statistically significant.
RESULTS
Clinical course
The patient groups were similar with respect to the demographic data (table 1).
The CABG patients typically had 3 grafts of which at least one arterial graft.
Intubation times, length of stay in the ICU and the hospital, use of inotropes
(dopamine, 5-8 mg/kg/min), postoperative blood loss and the overall postoperative
fluid balance were similar among the patient groups (table 2). One patient in group I
had a myocardial infarction. Two patients died: one patient in the control group IV
who developed a low output state and respiratory insufficiency, and one patient in the
arterial group I who had a massive gastro-intestinal bleeding on the ward.
The PaO2 decreased in the 4 groups over the different time points with a
significant time effect (p < 0.001). Although the residual group III had higher
postoperative mean values than the other groups, a significant group effect was not
present (p = 0.53, figure 1). The PaO2 values on the first postoperative day were
similar in all groups (table 2). The postoperative A-a gradients increased with a
significant time effect (p < 0.001). Although group III had the lowest mean values, a
significant group effect was not present (p = 0.62, figure 1). The A-a gradients on the
first postoperative day were similar in all groups (table 2).￿
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Haematology and biochemistry.
The leucocyte counts increased in all groups from the end of CPB towards the first
postoperative day with a significant time effect (p < 0.001). There was no difference
between the groups (p = 0.91). The lowest leucocyte counts on the first postoperative
day were observed in the residual group III in the arterial group I. There was a
significant difference between the leucocyte counts in group I and the venous group II
on the first postoperative day (table 2, figure 2). The granulocyte counts also increased,
showing a significant time effect (p < 0.001), but no difference between the groups  (p
= 0.07).  There was a significant difference between the granulocyte counts in group I
and group II on the first postoperative day (table 2, figure 2). Analysis of the results
with the type of operation, i.e. CABG or valve replacement, as a cofactor revealed a
significant (p = 0.04) effect on the leucocyte and granulocyte counts. The plateletI
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counts decreased at the end of the operation and then gradually increased, showing a
significant time effect (p < 0.001), but no difference between the groups (p = 0.49).
The elastase measurements showed two distinct patterns because a significant group
interaction was present (p = 0.005) (figure 3). At the end of the operation, the elastase
values were increased in the arterial group I (p = 0.03). After the operation, the elastase
values increased in the control group IV and venous group II. Repeated measurements
ANOVA  revealed a significant time effect (p = 0.02), but no group effect (p = 0.54).￿
￿
￿
￿
￿
æ
￿
￿
￿
￿
￿
"
ı
￿
￿
6
￿
￿
ł
:
￿
"
ı
￿
ø
9
œ
￿
ß
￿
￿
C
￿
+
￿
￿
￿
￿
￿
)
￿
F
￿
￿
ı
￿
￿
"
œ
￿
￿
)
æ
￿
￿
ı
>
￿
￿
￿
œ
￿
￿
￿
￿
p
œ
ı
￿
￿
œ
￿
￿
￿
￿
$
œ
￿
￿
A
ı
￿
￿
ı
￿
￿
￿
ı
￿
￿
￿
w
æ
@
ß
￿
￿
￿
￿
￿
ı
￿
￿
￿
￿
￿
￿
ı
￿
ı
￿
ı
￿
￿
￿
￿
￿
￿
￿
￿
)
æ
￿
￿
￿
n
￿
"
œ
￿
￿
h
æ
￿
F
ß
e
￿
￿
￿
"
￿
F
￿
￿
￿
+
￿
œ
￿
ß
￿
￿
æ
@
ß
￿
￿
￿
￿
+
ı
￿
￿
ß
￿
￿
$
æ
￿
￿
￿
$
ı
￿
￿
"
ı
￿
￿
￿
￿
￿
￿
￿
ß
￿
￿
n
￿
"
￿
￿
￿
;
￿
￿
￿
￿
￿
￿
￿
￿
￿
s
￿
C
ł
:
￿
￿
ı
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
 
￿
￿
!
#
"
$
￿
￿
￿
%
&
￿
’
(
￿
￿
)
￿
*
￿
￿
￿
+
￿
,
￿
￿
!
-
!
￿
.
/
￿
0
￿
￿
)
￿
*
￿
￿
￿
1
￿
￿
￿
/
￿
￿
￿
￿
￿
￿
!
2
"
￿
￿
)
￿
’
4
3
5
.
6
￿
7
9
8
:
￿
,
￿
￿
!
;
3
<
.
/
￿
￿
=
￿
￿
 
>
￿
"
￿
)
?
!
￿
.
￿
￿
@
"
￿
)
￿
!
A
￿
￿
)
￿
>
￿
"
$
￿
￿
C
B
￿
￿
￿
￿
 
￿
￿
=
￿
)
/
"
!
D
’
￿
*
￿
￿
￿
&
F
E
+
￿
G
!
D
.
￿
￿
I
H
;
￿
￿
￿
J
)
￿
"
￿
)
￿
K
(
￿
￿
1
L
!
￿
.
/
￿
?
1
A
"
￿
￿
 
>
￿
!
M
￿
N
￿
O
￿
P
A
N
￿
M
￿
Q
￿
R
 
S
￿
P
#
T
U
￿
Q
W
V
￿
S
￿
X
Z
Y
\
[
]
R
 
N
￿
^
￿
M
‘
_
b
a
c
Q
￿
^
￿
d
￿
N
￿
e
A
T
￿
c
P
￿
R
 
S
￿
P
2
T
N
￿
f
F
N
￿
e
￿
S
￿
R
b
P
A
Q
￿
R
g
T
S
￿
c
L
h
￿
c
N
￿
N
￿
V
F
P
￿
i
￿
R
￿
N
￿
^
￿
j
￿
i
￿
N
￿
^
￿
P
k
d
￿
S
￿
R
￿
V
l
T
N
￿
M
￿
^
￿
c
n
m
;
N
￿
f
￿
S
￿
R
￿
X
h
￿
X
￿
M
￿
S
￿
O
o
O
￿
p
L
[
]
R
 
N
￿
^
￿
M
q
_
r
_
b
a
c
Q
￿
^
￿
d
￿
N
￿
e
A
T
￿
c
P
￿
R
 
S
￿
P
2
T
N
￿
f
s
N
￿
e
t
S
<
M
￿
S
￿
R
b
P
u
N
￿
e
￿
P
D
i
￿
Q
s
U
￿
Q
￿
f
￿
N
￿
^
￿
O
s
R
 
Q
￿
P
￿
^
￿
R
v
f
W
h
￿
c
N
￿
N
￿
V
<
V
￿
^
￿
R
g
T
￿
f
￿
j
R
￿
Q
￿
w
u
S
￿
R
v
m
t
T
￿
f
￿
j
￿
p
[
]
R
 
N
￿
^
￿
M
x
_
y
_
r
_
b
a
c
Q
￿
^
/
d
￿
N
￿
e
A
T
￿
c
P
￿
R
 
S
￿
P
2
T
N
￿
f
z
N
￿
e
{
R
 
Q
￿
O
￿
T
V
￿
^
￿
S
￿
c
￿
i
/
Q
￿
S
￿
R
b
P
A
|
}
c
n
^
￿
f
/
j
~
m
￿
S
￿
d
￿
i
￿
T
￿
f
￿
Q
￿
h
￿
c
N
￿
N
￿
V
x
S
￿
e
￿
P
A
Q
￿
R
W
d
￿
S
￿
R
￿
V
l
T
N
￿
M
￿
^
￿
c
n
m
;
N
￿
f
￿
S
￿
R
￿
X
h
￿
X
￿
M
￿
S
￿
O
o
O
￿
p
s
[
￿
R
￿
N
￿
^
￿
M
￿
_
￿
\
a
@
d
￿
N
￿
f
￿
P
￿
R
 
N
￿
c
O
￿
w
u
T
P
￿
i
/
N
￿
^
￿
P
c
Q
￿
^
/
d
￿
N
￿
e
A
T
￿
c
P
￿
R
 
S
￿
P
2
T
N
￿
f
￿
Y
￿
￿
S
￿
c
n
^
￿
Q
￿
O
￿
j
￿
T
U
￿
Q
￿
f
￿
S
￿
R
 
Q
z
M
/
Q
￿
R
 
d
￿
Q
￿
f
￿
P
A
S
￿
j
￿
Q
￿
O
￿
N
￿
e
￿
￿
￿
A
￿
￿
￿
b
￿
2
￿
￿
￿
/
￿
￿
￿
￿
￿
￿
￿
n
￿
/
￿
￿
￿
u
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
:
￿
￿
￿
 
￿
￿
￿
￿
￿
￿
￿
 
￿
￿
￿
￿
￿
C
￿
￿
￿
￿
￿
￿
￿
¢
¡
￿
£
⁄
￿ m
¥
￿
ƒ
}
§
￿
¤
⁄
¥
￿
'
 
“
￿
«
￿
‹
@
›
r
›
￿
ﬁ
l
ﬂ
–
￿
0
† m
¥
￿
ƒ
‡
§
￿
¤
·
¥
￿
'
 
“
￿
«
￿
‹
￿
›
y
›
r
›
¶
￿
5
•
‚
ﬁ
￿
,
ﬂ
⁄
„ m
¥
￿
ƒ
‡
§
<
”
￿
»
￿
…
‰
¥
￿
'
 
“
￿
«
￿
‹
￿
›
¿
￿
•
5
†
`
￿
￿
￿
·
ˆ m
˜
￿
¯
‡
˘
￿
˙
:
¨
￿
￿
￿
˚
/
￿
￿
¸
￿
￿
A
￿
￿
˝
{
˛
;
￿
￿
¸
￿
ˇ
￿
—
￿
￿
 
￿
￿
˛
;
￿
￿
￿
￿
￿
A
ˇ
W
¸
￿
￿
/
¸
￿
￿
￿
￿
ˇ
￿
￿
ˇ
W
￿
￿
￿
k
￿
￿
¸
￿
￿
g
￿
¸
￿
￿
￿
￿
￿
￿
￿
 
￿
￿
￿
￿
￿
￿
¸
￿
￿
￿
￿
˝
￿
¸
￿
ˇ
￿
￿
˜
￿
￿
/
￿
￿
A
￿
￿
￿
¸
￿
￿
￿
￿
￿
￿
2
￿
￿
˛
￿
￿
￿
¯
g
˜
￿
￿
￿
￿
￿
—
￿
˚
￿
￿
￿
￿
￿
￿
A
￿
￿
￿
 
¸
￿
￿
￿
￿
2
￿
￿
￿
￿
k
￿
￿
￿
￿
￿
￿
˙
r
￿
5
￿
￿
￿
￿
Æ
J
￿
⁄
￿
￿
￿
￿
˝
l
￿
￿
￿
¸
￿
￿
#
￿
￿
￿
￿
˜
ª
￿
2
￿
:
￿
￿
˝
l
￿
ˇ
￿
￿
2
￿
￿
￿
/
￿
￿
￿
G
˚
￿
¸
￿
￿
}
￿
A
￿
￿
￿
v
￿
￿
ˇ
￿
˙
￿
￿
￿
¢
￿
9
˙
￿
￿
·
￿
?
￿
￿
￿
￿
￿
A
￿
:
￿
￿
￿
￿
￿
u
˜
￿
￿
 
￿
￿
—
￿
˚
￿
Ł
y
Ł
￿
¸
￿
￿
￿
˝
ª
˜
￿
￿
 
￿
￿
—
￿
˚
￿
Ł
y
Ł
r
Ł
￿
￿
￿
￿
ª
¸
￿
￿
/
¸
￿
￿
￿
￿
ˇ
￿
￿
ˇ
;
￿
￿
￿
+
￿
￿
¸
￿
￿
g
￿
¸
￿
￿
￿
￿
￿
￿
￿
˙
The elastase values decreased after the operation in the residual group III and arterial
group I. Analysis revealed a significant time effect (p = 0.01), but no group effect (p =
0.61). There was a significant difference in elastase levels on the first postoperative
day between group II and group III (p = 0.03) and between group III and group IV (p =
0.04).
Scanning electronmicroscopy.
The arterial filter (group I) had fibres of about 15 mm diameter and wide
interspaces of about 70 mm. The filter had a three-dimensional structure based on a
mesh of single fibres. Extensive platelet and protein deposits almost completely
covered the filter fibres and trapped cells (figure 4, a1). Many platelets, but very few
leucocytes were trapped in the superficial layer of the filter. In the two deeper layers of
the filter many leucocytes and red blood cells were present, often damaged as shown
by the rough, irregular shape (figure 4, a2 middle). Some red blood cells were caught
in the protein network. Platelets had pseudopodia indicating activation (figure 4, a2).
Platelet deposition decreased in the deeper layers of the filter.
The venous (group II) and residual (group III) filters had fibres of about 3 mm
diameter with narrow interspaces of about 10 mm. These filters had a similar three-
dimensional structure as the arterial filter. Two distinct cellular patterns were
observed, depending on the pressure applied. In the filters used under high pressure,
extended protein deposits were seen including fibrin networks (figure 4, b1). Leuco-Ø
5
Ø
cytes were mainly trapped in the middle and lower layer of the filter, where also some
damaged leucocytes were present (figure 4, b2 and b3). The platelets had a
predominantly rounded appearance (figure 4, b2), but in the superficial layer, many
platelets had pseudopodia (figure 4, b1). In contrast, in the filters used under low
pressure, leucocytes and platelets were predominantly located in the superficial filter
layer. The leucocyte and platelet entrapment was grossly reduced in the middle layer.
In the lower layer hardly any leucocytes and platelets were seen (figure 4c). There were
virtually no protein deposits. Only the platelets in the superficial layer had
pseudopodia. Leucocytes were in excess of the platelets.
DISCUSSION
In the cardiac surgical patients studied, we did not find a clinical difference among
the three filtration groups. Furthermore, there was no clinical difference between any
of the filtration groups and the control group, where no leucocyte filtration was
applied. As such, this study is essentially a negative one with respect to leucocyte
filtration. However, the finding of different patterns of leucocyte enptrapment with
different pressure and flow conditions is new and may explain some of the
controversies that exist about clinical leucocyte filtration.
The first leucocyte filtration strategy for cardiac surgical patients, which is
currently most common, is an arterial line filter used throughout CPB. However, the
effects on leucocyte counts and PaO2 resulting from this approach are conflicting.
7,14
We could not demonstrate a beneficial effect of arterial line filtration on postoperative
leucocyte counts, PaO2 and A-a gradients in this study. These findings are supported
by others.
10,14,15 At least two explanations can be found in the interpretation of the
SEM data. First, the leucocytes that are bound in the arterial line filter remain in the
circulation and thus are subjected to the high pressures, up to 200 mmHg, and high
flows, of 4-5 L/min, generated in the CPB circuit. The SEM data showed extensive
protein deposits, and leucocytes that were pressed into the middle and lower filter
layer.  These pressure and flow conditions can also explain the damaged leucocytes
that we found on SEM, and the increased elastase levels that we found at the end of
CPB. This is in agreement with Mihaljevic et al. who measured the elastase levels
before and after the arterial line filter and found an increase after the filter
14 and with
Mair et al. who also found increased elastase levels at the end of  CPB in their filter
group.
10 Second, despite the large blood volume filtered, the leucocyte counts at the
end of the operation were similar to the leucocyte counts in the other groups,
indicating that the arterial line filter had a low efficiency and efficacy. Again, an
explanation may be found in the SEM data, which show a filter with thick, wide
spaced fibres. Moreover, the short contact time between leucocyte and filter material,
caused by the high blood flow, may play a role as well, since an increase in contact
time between leucocytes and filter material improves filtration efficiency.
18
In the second strategy the filter was placed in a side branch of the venous line of
the CPB circuit in order to create low flow conditions. This approach increased the
contact  time  between  the  blood  and the filter to remove leucocytes more effectivelyŒ
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and had the advantage that the leucocytes caught in the filter were completely removed
from the circulation after a short period of time. However, this approach did not result
in clinical beneficial effects for at least two reasons. First, the procedure resulted often
in high pressures due to the design of the filter circuit with paired transfusion filters.
As can be seen from the SEM data, the leucocytes were pressed into the deeper filter
layers as with the arterial line filters. This could explain why this filtration procedure
despite the low flow resulted in high elastase levels after the operation. Second, this
filtration procedure lasted only about 10 min which was probably too short to produce
significant clinical effects. This is supported by the fact that this procedure resulted in
high levels of circulating leucocytes and granulocytes on the first postoperative day.
The third strategy, to filter the residual heart-lung machine blood before
transfusion into the patient, was based on the fact that blood that is transfused into the
patient first passes the lung. The lungs are vulnerable after CPB and also have to filter
the transfused, activated blood.
19 In this setting, low flow and low pressure conditions
were present as the blood was transfused under gravity. Indeed, the SEM data showed
undamaged leucocytes, located on the surface of the filter, and no protein deposits.
This may explain the observed low elastase levels on the first postoperative day.
Two shortcomings of this study exist. The first one is related to the filters used.
For safety reasons we used different filters (LG6 and RS1). This may have influenced
our results, despite the fact that the chemical composition of the filter material was
similar. This factor was in our opinion of less importance, as we wanted to compare
the different strategies of leucofiltration which are closely linked to differences in
volume filtered and type of filter used. More important however, may be the fact that
after prolonged use leucocyte depletion filters become saturated as a result of massive
cell deposition. For the arterial line filter this can occur after one hour of use. Despite
the fact that the mean CPB times in group I as a whole were longer than that, we did
not notice an extreme increase in arterial line pressure during CPB. However, we
cannot exclude that the longer CPB times in group I may have influenced the results of
the arterial line filtration negatively. The second shortcoming is that this study is
underpowered to detect clinical differences between the groups, due to the small
sample size and the fact that coronary artery surgery as well as valve operations were
included. This can be deduced from the 95% confidence intervals from table 2. Most
studies included only coronary artery bypass grafting. However we wanted to
demonstrate effects on a mixed population as is usual clinical practice.
In conclusion, we could in this study not demonstrate a clinical difference between
the filtered groups and between the filtered groups and the unfiltered control group.
However, the electronmicroscopic data show that the amount of debris is a function of
flow and pressure conditions. The results of this study also suggest that pressure might
be more important than flow with respect to the leucocyte damage. This study also
raises the question whether the filter itself caused the damaged cells, in other words
made debris out of normal cells. Future larger scale studies are therefore necessary to
evaluate the combined effects from different leucocyte depletion strategies on the
filters and their clinical implications.›
￿
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CHAPTER 6
THE RATIONALE FOR FAT FILTRATION DURING CARDIAC SURGERY
A.J. de Vries, Y.J. Gu, W. van Oeveren
Perfusion 2002;17:29-33￿
￿
￿
ABSTRACT
Improved filter technology may enable the removal of specific substances such as
lipids from the blood. Lipids form a heterogeneous group of compounds, but during
surgery main interest is focussed on triglycerides, glycerol and free fatty acids. Fat
emboli have been demonstrated in the brain after cardiac surgery and are associated
with ischaemic brain injury. Fat emboli have also been demonstrated in lung and
kidney tissue. Lung tissue and leucocytes are especially vulnerable to the effects of
free fatty acids. The surgical wound suction blood during cardiac surgery contains a
considerable quantity of micro emboli. Therefore, as a first step to determine the place
of fat filtration during cardiac surgery, the use of a fat removal filter for surgical
wound suction blood is advocated.￿
￿
￿
INTRODUCTION
From the early years of extracorporeal circulation, filtration techniques have been
used during cardiac surgery to prevent the transferral of micro embolism and to
prevent the deleterious effects of cardiopulmonary bypass (CPB) on the various organ
systems.
1,2 Screen filters have been used in various positions in the CPB circuit. Their
action is mainly depending on filter pore size. Application of these filters has lead to a
reduction of mortality after cardiac surgery.
3 However, these filters were of limited use
in removing fat particles due to the deformability of these particles.
Polymorphnuclear leukocytes and complement activation are known to play a central
role in the development of the systemic inflammatory response and organ reperfusion
injury in cardiac surgical patients.
4,5 Recently, with the development of newer filter
materials for so called depth filters, specific filters for removing leukocytes have
become clinical available. Depth filters promote the adhesion of leukocytes at the
inside of the filter by mechanical and physical bonding and lead to a reduction of
postoperative inflammatory response, especially for the lungs.
6,7
A next logical step would be the removal of other specific substances such as
lipids or cytokines by selective filtration. In this article we will review the composition
of fat in the human body and the effects of fat particles generated during cardiac
surgery and discuss the possible benefits of fat removal by filtration.
COMPOSITION OF FAT
Fat is a subset of the lipids. Fat is in fact an ester of fatty acids with glycerol,
while the lipids form a large group of compounds that are insoluble in water and
soluble in nonpolar solvents. Lipids in the human body can be distinguished in simple,
compound and derived lipids.
8 The simple lipids are esters of fatty acids with glycerol
as is shown in figure 1. These simple lipids form the majority of the body lipid stores
as neutral triglycerides, i.e. without electrical charge. It should be noted however, that
the triglycerides for the most part are mixed. This means that they consist of two or
three different fatty acids. The major components of fatty acids in the body are
palmitoleic acid, oleic acid, linoleic acid and arachidonic acid.
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The compound lipids consist for most part of phospholipids and glycolipids.
These compound lipids are mainly found in cellular membranes and in the myelinated
parts of the central nervous system.
Derived lipids are derived both from the simple and compound lipids by
hydrolysis and thus comprise fatty acids, glycerol, steroids and ketone bodies.
Cholesterol belongs to the lipids. It is not in itself a fat as it is not an ester of an
alcohol, but it is present in animal fat and is the basic compound of the steroids. It is
predominantly synthetized by the body itself. Normal fat intake in a western adult is
about 100 g triglyceride and 1 g cholesterol a day.
FAT RELEVANT TO CARDIAC SURGERY
The fat that we are interested in during cardiac surgery consists of the
subcutaneous fat, fat around organs (for example around the heart and in the
mediastinum), fat in the bone marrow and the fat that is present in the blood. The
situation during cardiac surgery, however, is different from the situation during
orthopaedic or trauma surgery, which are known for the generation of the fat
embolism syndrome. Sternal bone contains red marrow which has about 5% fat,
whereas the long bones yellow marrow which is present in contains about 85% fat.
9
Nonetheless, sternotomy has been associated with a rise in blood lipid content on the
first postoperative day.
10
Apart from the fat in the blood, we have to deal primarily with the neutral, simple
lipids. Surprisingly few studies have the composition of the fat in the different body
stores as a subject. It appears that the main fatty acid constituents of the subcutaneous
fat are palmitic acid (19-21%), oleic acid (41-44%) and linoleic acid (10-12%).
11,12
Lipids in blood plasma are bound for about 75% to lipoproteins. These lipoproteins are
water soluble complexes consisting of a layer of phospholipids covering triglycerides
and cholesterol esters (figure 2).
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The neutral fats can be broken down through the activity of the enzyme lipase A.
This leads to the formation of glycerol and fatty acids. Thus during surgery we will
encounter the intact neutral lipids and derived substances as glycerol, free fatty acids
and ketone bodies. Although the quantity of free fatty acids is small, they are
metabolic active. Depending on the number of unsaturated bindings they uncouple the
oxidative phosphorylation and inhibit the ADT-ATP exchange across mitochondrial
membranes.
13 This results in cell destruction.
ADVERSE EFFECTS OF FAT DURING CARDIAC SURGERY
Brain
Neurological damage after cardiopulmonary bypass (CPB) is a matter of major
concern, responsible for increased postoperative morbidity.
14 The neurological damage
can be linked to fat emboli through the studies of Moody and co-workers.
15 They
investigated post-mortem brain slices from patients who died after cardiopulmonary
bypass. Using specific staining for fat, they found many microemboli in the form of
small capillary and arteriolar dilatations (SCAD). These fat emboli are thus associated
with ischaemic brain injury.
Brooker and co-workers showed in a study with dogs, subjected to different forms
of CPB that only the application of suction and retransfusion of wound blood was
associated with an increase in density of SCADS.
16
Lungs
In animal experiments, injection of free fatty acids, particular oleic acid,
consistently produces the development of the acute respiratory distress syndrome.
17,18
It has also been shown that pulmonary epithelial permeability is increased after
embolisation with oleic acid, but not after embolisation with neutral fat.
19
Microemboli consisting of fat have been shown by electron microscopy in lung tissue
of patients after CPB.
20 Conversely, many patients with sepsis and acute respiratory
distress after trauma surgery show fat substances in alveolar macrophages.
21
Leucocytes
Oleic acid increases the activity of CD11b on leukocytes, thereby increasing the
adherence properties on the vascular wall.
22 This could explain the neutrophil
accumulation in the lungs and the development of respiratory distress syndrome.
Kidneys and other organ systems
Deposits of fatty material have also been demonstrated in kidney tissue at autopsy.
However, this was after CPB using a bubble oxygenator.
23 More recently, lipid
droplets could be demonstrated in urine samples from patients after cardiac surgery.
24
PROPERTIES AND APPLICATION OF FAT REMOVAL FILTERS
At this moment a fat removal filter is available that consists of a polyester depth
filter. This material is more or less the same as in leukocyte removal filters. However,
the internal architecture is different, leading to effective lipid removal. Recently, in a'
￿
“
laboratory study with reconstituted outdated packed red blood cells, it was found that
the filter removed 35% of the lipids.
25 The capacity of the filter is about 500 ml of
blood, which may limit its use during cardiopulmonary bypass. As there is a large
quantity of lipid microemboli in wound suction blood,
16,23 an application of a fat
removal filter in the cardiotomy suction line would be a logical first step. Given a
quantity of 1000ml for wound suction blood during CPB, this necessitates the use of
two filters. Besides, an application in cardiotomy suction blood would place the filter
in a low flow, low pressure circuit. Studies on leukocyte filtration have shown that the
efficiency of the filter depends on the contact time between blood and the filter
material.
26
HOW TO MEASURE FAT
Fat can be measured as fat globules in blood. This gives an impression of the
quantity of fat present and of the size of the emboli. After staining the fat globules can
be counted and sized in a counting chamber. This old method is often used in
conjunction with the clinical syndrome of fat embolism. Major drawback is that this
method does not give qualitative data.
A more qualitative approach gives the thin layer chromatography.
27 On a coated
glass plate a lipid mixture is applied. Then the plate is dipped in a solvent. Depending
upon the affinity for the solvent, the different constituents are separated as is shown in
figure 3. These separated fat components can be removed for further analysis.
Another approach is to measure directly the amount of triglycerides and
cholesterol in the blood by biochemical assay. This measurement is specifically aimed
at quantification of the neutral fat, which is biologically less active. The disadvantage
of this method is thus that the metabolic active free fatty acids are not measured.
Glycerol should in this setting also be measured. Glycerol is a necessary component of
the triglycerides and when the triglycerides fall apart in free fatty acids the glycerol
will be released. It is therefore also a measure for fat degeneration.
POSSIBLE CLINICAL APPLICATIONS
During CPB the blood removed from the wound by suction is commonly
retransfused into the patient in order to reduce homologous blood transfusion
requirements. The presence of a considerable quantity of microemboli in the wound
suction blood was demonstrated by Solis and co-workers as early as 1974.
23 It would
thus be beneficial for the patient to apply a fat removal filter for the cardiotomy
suction blood. However, the capacity of the available filter is rather small for this
application.
The filtration of the residual heart lung machine blood after cardiopulmonary
bypass deserves investigation. This blood is infused in the patient and passes the lungs
as a first organ. We have shown that leucocyte depletion of this blood improves
postoperative oxygenation.
7 Fat filtration of this blood could have the same benificial
effects. Furthermore, a major role for fat filtration should be in conjunction with the
application of a cell-saver device. Blood processed by a cell-saver is known to contain
a fat layer. The amount of fat present is dependent upon the type of cell-saver used.
28«
￿
«
In conclusion fat filtration is a promising new application of the concept of
filtering specific substances. At this moment investigations are under its way to
determine the place of fat filtration in clinical practice.
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CHAPTER 7
CLINICAL EVALUATION OF A NEW FAT REMOVAL FILTER
DURING CARDIAC SURGERY.
A.J. de Vries, J. Gu MD, Y.L. Douglas, W.J. Post, H. Lip, W. van Oeveren
European Journal of Cardio-thoracic Surgery 25 (2004) 261-266￿
￿
￿
ABSTRACT
Fat microemboli are generated during cardiac surgery that are associated with
postoperative organ injury. Recently, a fat removal filter has been developed, based on
a polyester leucocyte depletion filter. However, the efficacy of such a filter in a clinical
setting is unknown. In this study we tested the efficacy of this filter.
Coronary artery bypass patients were randomly divided in two groups. Group I:
filtration of cardiotomy suction blood during cardiopulmonary bypass with a fat
removal filter (n = 14). Group II: control patients without filtration (n = 14). Filter
efficacy was evaluated in group I using biochemical assays and thin layer
chromatography of blood samples taken simultaneously before and after the filter. In
addition, clinical and biochemical markers for organ injury were determined in both
groups.
We found that the fat filter removed triglycerides (0.9 ± 0.08 mmol.L
-1 vs. 0.63 ±
0.08 mmol.L
-1, p = 0.004, paired t-test), leucocytes (4.3 ± 0.8 x 10
9 vs.2.3 ± 0.6 x 10
9
.L
-1, p = 0.03), and platelets (116 ± 26 x 10
9 vs. 75 ± 21 x 10
9 .L
-1, p = 0.003) from the
blood samples taken before and after the filter. Chromatography showed a significant
reduction in free fatty acids, phospholipids and triglycerides. Clinically, leucocyte
counts were similar, but platelet counts were higher (181 ± 14 x 10
9.L
-1 v. 117 ± 8.6 x
10
9.L
-1 control, p < 0.001) in group I on the first postoperative day.
This study shows that the fat filter removed 40% fat, leucocytes and platelets from
cardiotomy suction blood during cardiac surgery. A larger scale study is necessary to
determine clinical effects on organ damage.￿
￿
￿
INTRODUCTION
Recently, fat microemboli have been demonstrated in brain tissue after
cardiopulmonary bypass (CPB).
1 These were related to retransfusion of cardiotomy
suction blood,
2 and associated with postoperative neurocognitive dysfunction.
3
Therefore, attention is again focussed on the adverse effects of retransfusion of
cardiotomy suction blood during cardiac surgery. In addition, the role of fat on organ
damage may have been underestimated, because fat microemboli have not only been
demonstrated in brain tissue after CPB, but also in lung tissue.
4 In animal experiments,
the injection of free fatty acids, particular oleic acid, consistently produces the
development of an acute respiratory distress syndrome.
5 Finally, fat deposits have been
demonstrated in kidney tissue
6 as well as in urine after CPB.
7
Several strategies are used to prevent retransfusion of cardiotomy suction blood.
Off-pump revascularization is increasingly performed, but is not suitable for intra-
cardiac surgery. In some centers the cardiotomy suction blood is completely
discarded,
8 but this may lead to increased allogenic transfusion requirements. Cell
savers are used to wash the wound suction blood, but their use is expensive, and the
quality of the processed blood is questioned.
9 Retransfusion of cardiotomy suction
blood, however, is still used during CPB, and thus a novel approach with a simple and
inexpensive filter for the removal of fat and debris from cardiotomy suction blood may
be an alternative. Such a fat removal filter has been developed. This is a polyester 40
mm screen filter, which is based on a leucocyte removal filter and allows high flow
transfusions. In a laboratory experiment this filter removed fat from reconstituted
blood.
10 In patients however, little is known about the performance of a fat removal
filter. The aim of this study was therefore to assess the efficacy of a fat removal filter
in a clinical setting by filtering cardiotomy suction blood during CPB in patients
undergoing coronary artery bypass grafting (CABG). As this study also served as a
pilot study for cardiotomy blood filtration on postoperative organ injury, we evaluated
some of the possible filter effects on lung, kidney and heart with clinical and
biochemical markers, using an unfiltered group of CABG patients as controls.
MATERIAL AND METHODS
Patients
After institutional human investigation committee approval and patient consent 28
patients scheduled for CABG were prospectively randomized to Group I: fat filtration
of cardiotomy suction blood during CPB (n = 14), or Group II: control patients without
filtration (n = 14). Exclusion criteria were pre-existing lung disease, cerebral vascular
disease, diabetes mellitus, emergency operation and re-operation. Blood samples were
drawn from the radial artery (1) after induction of anaesthesia, (2) at the end of the
operation, (3) after three hours in the ICU, and (4) on the morning of the first
postoperative day. From blood samples taken pre-operatively and postoperatively on
day 1, 2 and 6, the creatinin clearance was calculated according to the Cockcroft
formulae.
11￿
￿
￿
Anaesthesia and perfusion
Anaesthesia was induced and maintained by intravenous infusion of midazolam
(0.1 mg.kg
-1) and sufentanil (1.5 mg.kg
-1), as previously described.
12 Pancuronium (0.1
mg.kg
-1) was used for muscle relaxation. Dexamethasone (1 mg.kg
-1) was given after
induction. Ventilatory management was aimed at normocapnia throughout the
operation and in the intensive care unit (ICU), with an inspiratory oxygen fraction of
0.4, a positive end-expiratory pressure of 6 cm H2O and a tidal volume of 6-8 mL.kg
-1.
Bovine lung heparin (300 IU.kg
-1) was used for anticoagulation. This was monitored
by the celite activated clotting time (ACT) (International Technidyne, Edison, NJ,
USA) and maintained at a value ³ 400 s. After CPB, heparin was neutralized by
protamine (300 IU.kg
-1).
The extracorporeal circuit consisted of roller pumps (Stöckert, München,
Germany), a hollow fibre oxygenator (Sarns Turbo, 3M, St. Paul, MN, USA) and a
standard arterial line filter (Affinity 38µ Medtronic, Minneapolis, MN, USA). The
priming consisted of 500 mL hydroxyethylstarch 10% (Haes, Fresenius, Bad Homburg,
Germany) and 1000 mL lactated Ringer’s solution. Pump flow was adjusted to 2.4
L.m
-2 per min. Nasopharyngeal temperature during CPB was maintained at 32
oC.
Filtration procedure
In the filter group the cardiotomy suction blood was collected in a separate
cardiotomy reservoir (ATR120, Fresenius, Bad Homburg, Germany) from the moment
that the ACT was ³ 400 s. After aortic cross clamp release this cardiotomy blood
passed under gravity through a fat removal filter (LipiGuard, Pall, Portsmouth, UK)
into the cardiotomy reservoir of the CPB circuit. After each 600 mL of cardiotomy
blood a new filter was used. In the control group the cardiotomy suction blood was
collected directly in the cardiotomy reservoir of the CPB circuit from the moment that
the ACT was ³ 400 s.
In both groups, the residual blood in the extracorporeal circuit after CPB was
collected in a transfusion bag and transfused into the patient using a standard
transfusion system.
Measurements
When 200 mL blood had passed through the filter, samples were taken
simultaneously before and after the filter. From EDTA-anticoagulated blood,
haematocrit, platelet and total white blood cell counts were determined by an
electronic cell counter (Cell-Dyn 610, Abbott, Santa Clara, CA, USA). Triglyceride
levels were determined with a biochemical assay (Sigma, St. Louis, MO, USA).
To assess the capacity of the filters blood samples were taken from 4 additional
filters in separate patients after 50 mL, 200 mL and 600 mL of blood had passed
through the filter. From these samples platelet and total white blood cell counts, and
triglyceride levels were measured as before.
In addition, to assess the qualitative effects of filtration, modified thin layer
chromatography according Folch
13 was performed on samples before and after the
filter and on a patient blood sample before CPB, as well as on the blood samples that
were taken for the assessment of the filter capacity. Briefly, plasma was extracted with
a chloroform-methanol mixture. The extract was mixed with butylated hydroxytoluene
to avoid oxidation and after drying solved in chloroform. On a silica plate 10 mL￿
￿
￿
samples were applied. This was run with a mixture of n-hexane-diethylether-acetic
acid and developed with cupper sulphate in fosforic acid. Five bands were discerned:
cholesteryl esters, triglycerides, free fatty acids, cholesterol and phospholipids. For a
semiquantitative evaluation of the chromatography, the bands were scanned by
computer and the intensity of the bands was attributed a score from 0, being totally
white to 100, being totally black. The values given in table 3 are these computerized
density scores.
As we found a significant preservation of platelet counts after filtration including
significant higher postoperative circulating platelet counts in the filtration group, we
retrospectively analyzed the adsorption of the filter material of platelet activating
factor. Therefore, we incubated 40 mg pieces of filter material with 0.05 mM purified
platelet activating factor (PAF) C-18 (Sigma, St Louis, Mi, USA) which was then
added to fresh platelet rich plasma from healthy volunteer blood. Platelet aggregation
was compared between PAF C-18 with or without pre-incubation with filter material
by means of optical aggregometry (Chronolog, Havertown, PA, USA).
Statistics
The sample size for this study was calculated on the assumption that the fat filter
would remove at least 50% of the fat from the surgical cardiotomy suction blood.
Twelve patients would therefore be needed with an power of 0.8 and an a of 0.05. All
data are presented uncorrected for haemodilution and expressed as mean ± standard
error unless otherwise stated. For comparison of single data between the groups a two-
tailed Student’s t-test was used. For comparison of the measurements before and after
the filter a paired Student’s t-test was used. Two way analysis of variance (ANOVA)
for repeated measurements was used to determine the effects of time, group and
interaction over the different time points. In case of multisample sphericity
Greenhouse-Geisser (}) adjustments were made. To allow for multiple comparisons
the results were corrected using the least square difference method. A p-value  0.05
was considered statistically significant.
RESULTS
Both groups were similar with respect to age, sex, length, weight, haematocrit (p =
0.16), creatinin clearance, grafts and CPB time (p = 0.2). The demographic data are
summarized in table 1.
Filter characteristics
The amount of cardiotomy suction blood was 1104 ± 152 mL. with a haematocrit
of 19 ± 1.4%. Baseline plasma triglyceride level in the patients was 1.02 ± 0.15 mmol.
L
-1. The filter removed 30% of the triglycerides and reduced leucocytes by 47% and
platelets by 35% (table 2). Thin layer chromatography revealed that after filtration, free
fatty  acids  (FFA),  triglycerides  and  phospholipids  were reduced (table 2). The
efficacy  of  the  filter  decreased  slightly  during  the  600  mL  of  blood  that  passed
through the filter. After 600 mL of blood the filter removed 13% of the triglycerides
and reduced leucocytes by 34% and platelets by 31%. Thin layer chromatography of￿
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these four filters after 600 mL revealed the same pattern as after 200 mL, with
reductions in FFA, triglycerides and phospholipids. The time needed to pass 200 mL
of blood under gravity at a height of 90 cm was 2 min 40s ± 13s, and for 600 mL this
time was 7 min ± 20s. We found no adsorption of (hydrophobic) platelet activating
factor (PAF) on the filter material, excluding its effect on the preservation of the blood
platelets.
Clinical effects
The calculated creatinin clearance was higher in the filter group on the first
postoperative day (p = 0.04) (tables 1 and 3). The two groups were similar with respect
to fluid intake, diuresis, blood loss, lung function and myocardial injury (table 3). In
the control group, one patient had a myocardial infarction (defined as new  Q-wave  on
the ECG and CK > 180 U/L with CK-MB > 10% of total), one patient had major blood
loss and one patient developed renal function disturbances with a serum creatinin level
of 231 mmol.L
-1. Overall hospital stay was slightly shorter in the filter group (table 3).
It is noted that the attending ICU and hospital staff were blinded to the study groups.
The PaO2 showed a time effect (p = 0.001), but there was no difference between
the groups (p = 0.25) (figure 1). The A-a gradients showed a time effect (p < 0.001),
but no difference between the groups (p = 0.25) (figure 1).
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The postoperative platelet counts on the first postoperative day were higher in the
filter group than in the control group (figure 2, table 3). There was a time effect (p <
0.001) and a difference between the groups (p = 0.04). The postoperative circulating
leucocyte counts were similar in both groups. There was a time effect (p < 0.001), but
there was no difference between the groups (p = 0.08) (figure 2).
DISCUSSION
This study showed that the application of a fat removal filter reduced the fat
content of cardiotomy suction blood in cardiac surgical patients. The filter removed
46% of the free fatty acids and 30% of the triglycerides as shown by thin layer
chromatography and plasma samples.
The mechanism for fat removal is not clear. The filter consists of tightly packed
fibers with a porous structure of about 40 mm. This may mechanically stop the larger
fat globules. Such a view is supported by a recent study on cardiotomy suction blood.
14
Fat microemboli were divided in large (> 50 mm) and small (10-50 mm) size emboli. In
a subset of 6 patients an additional filter was placed after the cardiotomy reservoir. No
large emboli were detected after the filter. In our filter the removal of the various fat
subgroups was highly variable. This may be explained by a difference in electrostatic￿
￿
￿
adhesion to the filter material. The thin layer chromatography supports this view,
because the more polarized substances as the free fatty acids were removed more
effectively. One could therefore speculate on filter improvement by coating of the
fibres to increase the removal of the other subgroups, but clinically the free fatty acids
appear to be the most important. Increased levels of free fatty acids have documented
effects. In pancreatic tissue b cells are damaged.
15 In kidney tissue tubulointerstitial
damage is aggravated.
16 In lung tissue free fatty acids are associated with the
development of an acute respiratory distress syndrome.
5 In endothelial cells free fatty
acids cause vasoconstriction and granulocytes are activated through surface expression
and activity of CD11b.
17
We found a lower overall efficacy of the filter in the clinical setting of our study
than previously reported in a laboratory setting with reconstituted blood.
10 It has
recently been shown that the composition of the cardiotomy suction blood is different,
and that a low temperature increases filter efficacy.
18 This could explain our results
and is supported by another clinical study that also showed a moderate efficacy of this
filter in 3 orthopaedic patients.
19 Free fatty acids are bound to albumin. Plasma
albumin is reduced by haemodilution after CPB. For this reason we did not use a prime
with albumin, but instead used hydroxyethylstarch, which is not known to interfere
with binding of free fatty acids.
With about 85 mL/min the filter appeared to have a high flow during transfusion
under gravity. However, a high flow reduces the contact time between blood and filter
medium and thus may result in a lower filter efficiency.
20 Thus, filter efficiency may
be improved by coating the fibers, or alternatively by packing more filter materials in
the housing. This latter option would reduce the flow over the filter. However, a flow
of 30 mL/min should be sufficient to filter 1.5 L, which equals the amount of
cardiotomy suction blood, during a cross clamp time of 45 min. For widespread use
the fat removal filter will need a larger capacity, as our results indicated that the filter
became saturated after 600 mL, requiring to change it.
We did not measure lipoprotein levels in this study. Lipoproteins consist of a layer
of phospholipids which covers triglycerides and cholesterol esters. These complexes
are necessary to facilitate lipid transport through the plasma compartment. The
objective of the identification of the several subgroups of lipoproteins lies in their
contribution to the atherosclerotic risk profile. That was not the purpose of this study.
Moreover, we speculated that fat release during the operation would mainly result
from mechanical damage through surgical manipulation and shear forces. This would
result in a direct release of the triglycerides and free fatty acids, which we measured.
Several clinical findings in this small pilot study suggest a beneficial effect of the
filter. First, the higher calculated creatinin clearance in the filter group on the first
postoperative day in view of a similar postoperative fluid balance. Fat emboli have
been demonstrated in the kidney after CPB,
6 and also after experimental fat embolism
syndrome.
21
The second is the higher postoperative platelet counts in the filter group. Platelets
and leucocytes in the cardiotomy suction blood are activated in the presence of fat and
tissue factor from the pericardium.
22 Thus, removal of platelets and leucocytes by the
filter may be advantageous and protective against the systemic inflammatory response
and thrombus formation.æ
￿
æ
It has been reported that activated platelets do not remain in the circulation but are
actively cleared.
23 This may explain the higher postoperative circulating platelet counts
in the filter group, suggesting that the platelets were less activated than in the control
group. Direct adsorption of platelet activating factor by the filter was not shown as a
mechanism of higher circulating platelet counts after filtration. We have not
determined b-thromboglobulin levels, as the effects of the filter on the circulating
platelet counts were not expected. Measurement of leucocyte activation, for example
by determination of CD11/CD18, could have clarified the slightly higher postoperative
circulating leucocyte counts in the filter group, because it is known that free fatty acids
result in surface expression and activity of CD11b on human neutrophils.
17
Third is postoperative oxygenation. Although not significant different in itself due
to the small sample size, the fact that the postoperative A-a gradients were smaller, and
the postoperative PaO2 values were higher in the filter group suggest that in the filter
group less pulmonary injury occurred. This may be explained by the fact that the filter
significantly reduced free fatty acids, known for their deleterious effects on lung
function.
5 In addition, the filter also removed a significant part of the leucocytes from
the suction blood. We have previously shown that filtration of leucocytes improved
postoperative lung function.
24
Several other possibilities for the management of the cardiotomy suction blood
exist. Cell savers are increasingly used, but these devices might be less than ideal for
several reasons. First, fat is not completely removed by cell savers.
25,26 Thus, as a
consequence, even cell saver blood may benefit from the application of a fat removal
filter before retransfusion. Second, their use is expensive and requires attention and
time to process. In contrast, fat removal filters are cheaper, about 25% of the cost of a
cell saver, they are very easy to operate and processed blood is immediately available.
Kaza found cell savers not more effective than the application of a filter after the
cardiotomy reservoir for the elimination of small and large fat emboli.
14 Third,
processed cell saver blood contains increased levels of interleukin-1
9 and activated
leucocytes,
27 which may aggravate the inflammatory reaction associated with CPB.
There are shortcomings in this study. It was underpowered to detect clinical
differences between the groups. Based on our results, at least 35 patients in each group
had to be included to demonstrate clinical differences with a power of 0.8 and an a of
0.05. However, our results suggest that it would be worth to perform such a study.
Further, we use routinely dexamethasone for all our patients to reduce the
inflammatory reaction after CPB. The incidence of the fat embolism syndrome was
decreased in a prospective randomized clinical trial, where steroids were given to
prevent the effects of the fat embolism syndrome.
28 Therefore, the effects of the fat
removal filter on organ damage could be more pronounced than demonstrated in this
study. Third, we did not use a separate cardiotomy reservoir in the control group.
Instead, the cardiotomy blood was gradually mixed with the patients’ blood during the
whole CPB period as usual. This gradual mixing may have reduced the effects of the
transfusion of cardiotomy blood in the control group.
In conclusion, our results demonstrate that the fat removal filter removed
approximately 40% of fat, leucocytes and platelets from cardiotomy suction blood. The
efficiency and capacity of the filter should be improved and a prospective study of the
effects on postoperative organ damage should be performed. The application of a fat
filter however, is not the ultimate answer to a reduction of microemboli. It is estimated￿
￿
￿
that 60% of the emboli during surgery are caused by surgical manipulation.
3 However,
the presence of cerebral fat microemboli justify that every effort is done to reduce the
fat load for the patient.
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CHAPTER 8
THE CLINICAL APPLICATION OF A FAT REMOVAL FILTER:
BIOCHEMICAL RESULTS AND CELL COUNTS.
A.J. de Vries, Y.J.Gu, A.H. Epema, P.W. Boonstra, W. van Oeveren
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ABSTRACT
Retransfusion of cardiotomy suction blood during cardiac surgery is associated
with cerebral microemboli and an inflammatory reaction. Recently, a fat removal filter
has been introduced, but little is known about the clinical effects. To assess the effects
of this filter we measured biochemical markers and cell counts in patients.
Randomized prospective study in elective cardiac surgical patients (n = 28).
During cardiopulmonary bypass the cardiotomy suction blood was filtered with a fat
removal filter and retransfused in 14 patients (filter). In 14 patients the cardiotomy
suction blood was discarded (waste). Triglyceride and glycerol, and neuron-specific
enolase (NSE) and S-100b as brain injury markers, and circulating total white blood
cell and granulocyte counts and interleukin-6 as inflammatory markers were measured.
The filter removed triglycerides (0.9 ± 0.08 mmol.L
-1 v. 0.63 ± 0.08 mmol.L
-1, p =
0.004), leucocytes (4.3 ± 0.8 x 10
9.L
-1 v. 2.3 ± 0.6 x 10
9.L
-1, p = 0.03) and platelets
(116 ± 26 x 10
9.L
-1 v. 75 ± 21 x 10
9.L
-1, p = 0.003, paired t-test) from the cardiotomy
blood. Apart from a transient increase in S-100b and NSE values in the filter group,
there was no difference between the groups on the first postoperative day (S-100b 0.28
± 0.05 mg.L
-1 filter vs. 0.29 ± 0.04 mg.L
-1 waste; NSE 16.7 ± 1.5 ng.L
-1 filter vs. 14.9 ±
0.9 ng.L
-1 waste). Triglyceride levels on the first postoperative day were similar. Total
white blood cell (p = 0.009) and granulocyte counts (p = 0.01, both repeated
measurements ANOVA) were higher in the filter group.
The filtration related transient increase in brain markers and the higher white
blood cell and granulocyte counts in the filter group suggest that the filter efficacy
should be improved.ß
￿
￿
INTRODUCTION
Retransfusion of cardiotomy suction blood during cardiopulmonary bypass (CPB)
is used in cardiac surgery as a cost effective way to reduce the number of allogenic
blood transfusions.
1 However, this practice may be questioned for at least two reasons.
In the first place, cardiotomy suction blood that is retransfused, contains many fat
emboli.
2 The use of cardiotomy suction is associated with an increase in cerebral
emboli.
3 These emboli are largely responsible for the postoperative neurocognitive
dysfunction that affects up to 30% of the patients 3 months after cardiac surgery.
4,5
A second problem with retransfusion of wound blood is an inflammatory reaction
in the patient. The activation of cardiotomy blood in the presence of fat and tissue
factor from the pericardium 
6 leads to a high concentration of platelet- and leucocyte-
derived microparticles which are involved in the systemic inflammatory response after
CPB.
7,8 Increased concentrations of the pro-inflammatory agent interleukin (IL)-6 in
wound blood have also been related to febrile reactions after retransfusion.
9
Recently, a fat removal filter has been developed that is suitable for retransfusion
of wound blood. This is a high flow polyester screen filter, based on a leucocyte
removal filter. During cardiac surgery a beneficial effect from the application of this
filter was suggested 
10, and a moderate clinical effect was observed in orthopaedic
surgery.
11 For this study we hypothesized that the application of a fat removal filter for
the cardiotomy suction blood would have a positive effect on brain injury and the
inflammatory response after CPB as assessed by biochemical markers and cell counts.
Serum levels of the brain injury markers neuron specific enolase (NSE) and S-
100b can be measured, but S-100b has been demonstrated in cardiotomy suction
blood.
12 However, NSE and S-100b can still be used as markers for brain dysfunction
if extracerebral sources are controlled for.
13 The best option for control is to discard
the cardiotomy suction blood completely. This has the additional advantage that the
systemic inflammatory response after CPB also will be minimized. Therefore, we
compared in this study a group of patients in which we filtered and retransfused the
cardiotomy suction blood during CPB, with a control group of patients in which we
discarded the cardiotomy suction blood completely. Use of an effective fat removal
filter would result in similar postoperative values for markers of brain injury and
inflammation in both groups. As markers for brain injury we measured the serum
levels of NSE and S-100b, triglycerides and glycerol, and as inflammatory markers
total white blood cell, granulocyte and platelet counts and IL-6 levels.
MATERIAL AND METHODS
Patients
After institutional human investigation committee approval and patient consent 28
consecutive patients scheduled for elective coronary artery bypass grafting were
prospectively studied. They were on the operating day with a computer generated
randomization table allocated to either a filter group (n = 14), in which cardiotomy
suction blood throughout the CPB period was filtered and retransfused, or a waste
group (n = 14), in which the cardiotomy suction blood throughout the operation was
discarded. This number of patients was calculated as follows. We estimated that a￿
!
￿
difference of one standard deviation between the S-100b and NSE values after
induction of anaesthesia and on the morning of the first postoperative day would be
clinically relevant. It was therefore estimated that 14 patients in each group would be
required to have a power of 0.8 at an a of 0.05 in order to detect a significant
difference among the groups. Patients with redo-operations, with pre-existing cerebral
disease or with a recent (<1 month) myocardial infarction were excluded.
Anaesthesia and perfusion
Anaesthesia was induced and maintained according to an established protocol
14
and consisted of infusion of midazolam (0.1 mg.kg
-1) and sufentanil (1.5 mg.kg
-1).
Bovine lung heparin (300 IU.kg
-1) was used for anticoagulation. This was monitored
by the celite activated clotting time (ACT)(International Technidyne Co., Edison, N.J.,
USA) and maintained at a value ³ 400 s. After CPB, heparin was neutralized by
protamine (300 IU.kg
-1). The extracorporeal circuit consisted of roller pumps (Stöckert
Istrumente, München, Germany), a hollow fibre oxygenator (Sarns Turbo, 3M, St.
Paul, Minn., USA) and an arterial line filter (Affinity 38m, Medtronic, Minneapolis,
Minn., USA). The priming consisted of 500 mL hydroxyethylstarch 10% (Haes 10%,
Fresenius, Bad Homburg, Germany) and 1000 mL lactated Ringer’s solution. Pump
flow was adjusted to 2.4 l.m
-2.min
-1. Nasopharyngeal temperature during CPB was
maintained at 32
oC and a-stat pH-management was used.
Filtration procedure
In the filter group, the cardiotomy suction blood was collected in a separate
cardiotomy reservoir (ATR120, Fresenius, Bad Homburg, Germany) from the moment
that the ACT was ³ 400 s. After aortic cross clamp release this wound suction blood
passed under gravity through a fat removal filter (LipiGuard, Pall Biomedical,
Portsmouth, GB) into the cardiotomy reservoir of the CPB circuit. After each 600 mL
of suction blood a new filter was used in order not to exceed the recommended filter
capacity.
In the waste group, the cardiotomy suction blood was aspirated with the hospital
wall suction system and discarded.
15
After CPB, the residual blood in the heart-lung machine was collected in a
transfusion bag and in both groups retransfused to the patients. Postoperative shed
mediastinal blood was not retransfused. Postoperative transfusion of homologous
blood products was according to our hospital guidelines. The staff of the intensive care
unit (ICU) was blinded to the study groups.
Measurements
For all laboratory tests and biochemical assays EDTA and citrate anticoagulated
blood was drawn from the patients’ radial artery catheter. Blood samples were drawn
(1) after induction of anaesthesia, before the start of CPB, (2) at the end of the
operation, (3) after three hours in the ICU and (4) on the morning of the first
postoperative day. For biochemical assays, plasma was obtained by centrifugation of
whole bood at 1000g and immediately stored at –80
oC for further determinations.
Serum levels of S-100b and neuron specific enolase (NSE) were both determined
using enzyme immunoassays (Sangtec Medical, Bromma, Sweden). Interleukin-6 was
determined using an enzyme immunoassay (Quantikine, R&D Systems, Minneapolis,￿
￿
￿
Minn, USA). Plasma levels of glycerol and triglyceride were both determined by
routine biochemical methods (Sigma. St. Louis, MO., USA). Haemoglobin,
haematocrit and platelet, total white blood cell and granulocyte counts were
determined by an electronic cell counter (Cell-Dyn 610, Abbott, Santa Clara, CA,
USA). Levels of triglycerides, and leucocyte and platelet counts were measured in
addition from EDTA and citrate anticoagulated samples taken simultaneouly before
and after the filter to assess the efficacy of the fat removal filter.
Statistics
All data are presented uncorrected for haemodilution and expressed as mean ±
standard error. For comparison of single data between the groups a two tailed
Student’s t-test was used. For comparison of the measurements before and after the
filter the paired Student’s t-test was used. To identify group, time, and group-time
interactions two way analysis of variance (ANOVA) for repeated measurements was
used. To allow for multiple comparisons the Bonferroni adjustment was applied.
Correlations were calculated by means of the Pearson correlation coefficient. A p-
value  0.05 was considered statistically significant.
RESULTS
All patients that were included completed the study. The demographic data are
summarized in table 1, which shows that both groups were similar. The postoperative
clinical data are summarized in table 2, and indicate that there were no differences
between both groups.
There were no complications requiring a prolonged hospital stay. The fat filter
removed triglycerides (0.9 ± 0.08 mmol.L
-1 v. 0.63 ± 0.08 mmol.L
-1, p = 0.004),
glycerol (5.7 ± 0.37 mmol.L
-1 v. 4.5 ± 0.44 mmol.L
-1, p = 0.05), leucocytes (4.3 ± 0.8 x
10
9.L
-1 v. 2.3 ± 0.6 x 10
9.L
-1, p = 0.03) and platelets (116 ± 26 x 10
9.L
-1 v. 75 ± 21 x
10
9.L
-1, p = 0.003) from the cardiotomy suction blood (1103 ± 154 mL). Compared to
the baseline preoperative serum levels in the patients (figures 1 and 2), leucocyte and
platelet counts were lower in the cardiotomy suction blood, the triglyceride levels were
similar, but the glycerol levels were higher.
The release pattern over the time of the brain marker S-100b was different in both
groups. A significant interaction between group and time was observed (p = 0.006,
figure 1). This was due to a transient peak at the end of the operation in the filter
group. On the first postoperative day however, S-100b serum levels were similar again
(0.28 ± 0.05 mg.L
-1   filter vs. 0.29 ± 0.04 mg.L
-1 waste, figure 1). The NSE serum levels
also showed a transient peak in the filter group, but there was no significant interaction
between group and time (p = 0.07, figure 1). This peak was about 3 hours
postoperatively. However, repeated measurements ANOVA revealed that the two
groups were not different (p = 0.37, figure 1). The NSE serum levels in both groups on
the first postoperative day were higher than the preoperative serum levels (figure 1),
but this was not the case for the S-100b levels.  The NSE serum levels at the end of the
operation showed a weak positive correlation with the S-100b serum levels at the end
of the operation (r = 0.4, p = 0.04).￿
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Analysis of the glycerol levels over the time revealed a difference between the two
groups (p = 0.04, figure 1), but this was not the case for the triglyceride levels (p =
0.49, figure 1). The glycerol and triglyceride serum levels on the first postoperative
day were not different between the groups (triglycerides 0.63 ± 0.07 mmol.L
-1 filter vs.
0.73 ± 0.11 mmol.L
-1 waste; glycerol 1.27 ± 0.18 mmol.L
-1 filter vs. 1,11 ± 0.2
mmol.L
-1 waste, figure 1).
The total white blood cell counts increased during the study period (p < 0.001) and
were different between the groups (p = 0.009, figure 2). This resulted in higher total
white blood cell counts in the filter group on the first postoperative day. Similarly, the
granulocyte counts, as the more reactive part of the white blood cells, increased during
the study period (p < 0.001) and were higher in the filter group (p = 0.01, figure 2). A
positive correlation between the granulocyte counts and the CPB time was present in
the waste group (r = 0.69, p = 0.007), but this was not the case in the filter group (r =
0.21, p = 0.48).
Although the IL-6 levels were higher in the waste group on the first postoperative
day (33.6 ± 5.9 ng.L
-1) than in the filter group (15.0 ± 5.7 ng.L
-1), there was no
difference between the two groups over the time (p = 0.43, figure 2).￿
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DISCUSSION
In this study in cardiac surgical patients, we did not observe different serum levels
of NSE and S-100b on the first postoperative day, whether we retransfused the
cardiotomy suction blood after passage through a fat removal filter, or completely
discarded this blood. This finding suggests that the application of a fat removal filter is
effective. However, we also observed a transient increase in serum levels of NSE and
S-100b in the filter group. The serum levels of S-100b had a peak at the end of the
operation, whereas the serum levels of NSE had a peak about 3 hours later. In addition,
the glycerol levels and the total white blood cell and granulocyte counts, as
inflammatory markers, were higher in the filter group. These findings suggest that the
efficacy of the filter should be improved.
NSE and S-100b are both sensitive and early markers for brain injury.
16,17 NSE
levels increase by cell destruction in the gray matter. An increase in serum NSE on the
first postoperative day is associated with neuropsychological dysfunction.
18 In contrast,
S-100b is released from cells in the white matter.  Increased S-100b levels on the first￿
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postoperative day are associated with cerebral injury, but may be difficult to evaluate
after cardiac surgery due to extracerebral S-100b sources.
12 Thus, depending on the
type of cell damage, the combination of the NSE and S-100b release may be more
specific for brain injury,
16,19,20 and we determined therefore both NSE and S-100b
serum levels.
The clinical efficacy of the fat removal filter appeared insufficient for several
reasons, despite the significant reduction in triglycerides, glycerol, leucocytes and
platelets in the retransfused cardiotomy blood, and despite the similar NSE and S-100b
serum levels on the first postoperative day in both groups. In the first place, the
postoperative increase in NSE suggests at least some brain injury in the filter group,
because it has been shown that NSE did not increase after abdominal surgery.
21 A
second argument for an insufficient clinical efficacy of the fat filter, is the higher total
white blood cell and granulocyte counts in the filter group. Moreover, in the waste
group the postoperative total white blood cell and granulocyte counts correlated with
the CPB time as was expected.
22 This was not the case in the filter group, and suggests
that retransfusion of the filtered cardiotomy suction blood had a more profound effect
on the inflammatory parameters than CPB itself.@
=
@
A low filter capacity might explain the insufficient filter efficacy, but this is less
likely as we frequently changed the filter according to the manufacturer’s instructions.
Others however, also felt that the filter efficacy should be improved. After orthopaedic
surgery, postoperative wound blood was passed through a fat reducing filter which was
found to be inferior to a leucocyte depletion filter.
11 This finding is supported by a
laboratory study with reconstituted blood and soya oil, in which a leucocyte depletion
filter was also more effective than the fat removal filter.
23
We confined ourselves to the assessment of biochemical markers because of the
small scale of this study. We also did not estimate the number of fat microemboli, but
instead used triglyceride and glycerol measurements for several reasons. It has already
been demonstrated that the application of a filter before retransfusion of cardiotomy
blood prvented the passage of fat emboli larger than 50 mm.
24 This is most likely based
on the mechanical removal of the fat emboli. Moreover, the assessment of the number
and size of the microemboli reflects only neutral fat, which is biologically not active.
During surgery however, triglycerides break down in glycerol and free fatty acids.
Especially the free fatty acids are associated with organ damage, for example in the
lungs.
25 These slightly polarised substances are also removed by the filter through the
electrical charge of the fibers.
10 Therefore the glycerol and triglyceride measurements
may more accurately reflect organ damage.
The neurological effects of clinically applied filtration techniques have not been
assessed before. Only Kincaid et al. processed cardiotomy suction blood in dogs with a
cell saver and passed this blood through a leucocyte depleting filter in a subset of 6
dogs. They found no difference in cerebral microemboli compared to processed, but
unfiltered blood.
26 Their findings support our results with respect to the NSE and S-
100b serum levels on the first postoperative day. However, serum levels of brain
injury markers may not directly be related to clinical impairment, as a deficit in one
region of the brain may have more pronounced clinical effects than that same deficit in
another region of the brain. Consequently, a larger scale study is necessary to
demonstrate clinical important differences.
In conclusion, the results of this study do not demonstrate a difference in S-100b
and NSE values on the first postoperative day. However, the filtration related transient
increase in brain injury markers and the higher leucocyte and granulocyte counts
suggest that the filter efficacy should be improved. A larger scale clinical study is
therefore necessary before widespread application of a fat removal filter can be
recommended.
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Activated leucocytes play a key role in the generalized inflammatory response that
occurs after cardiac surgery. They have a pivotal role in reperfusion injury after
ischaemia, and also interact with the vascular endothelium and the cardiopulmonary
bypass circuit. This generalized inflammatory response leads to postoperative tissue
injury. To minimize or even prevent postoperative tissue injury, it is thus indicated to
modify the effects of leucocytes. Various anti-inflammatory strategies have been tried,
such as the coating of the cardiopulmonary bypass circuit, pharmacological
interventions as the use of corticosteroids and aprotinin and the use of a cell-saver for
the washing of wound blood. Removal of leucocytes by means of a filter, however,
seems to be the most effective treatment. Good results have been achieved with
leucocyte depletion in the setting of ischaemia and reperfusion. However, not only
activated leucocytes are associated with postoperative tissue injury, but also
retransfused fat. Fat emboli have been demonstrated in the brain after cardiac surgery
and are associated with ischaemic brain injury. Fat emboli have also been
demonstrated in lung and kidney tissue.
Improved filter technology may thus include the removal of various harmful
substances such as fat from the blood. Thus, the aim of this thesis as outlined in
chapter 1, was to demonstrate that leucocyte and fat filtration, applied in the setting of
cardiac surgery, have a beneficial effect on inflammatory markers and postoperative
organ injury.
Conflicting results have been reported about the clinical effects of leucocyte
depletion with an arterial line filter during the whole period of cardiopulmonary
bypass. Therefore, in chapter 2 a new leucocyte depletion method is described. In a
randomized prospective study in thirty patients undergoing elective cardiac surgery, we
investigated whether leucocyte depletion from the residual heart-lung machine blood at
the end of cardiopulmonary bypass would improve lung function and reduce the
postoperative inflammatory response. In the leucocyte-depletion group all residual
blood was filtered by leucocyte depletion filters before reinfusion in the patient,
whereas in the control group an identical amount of residual blood was reinfused
without filtration. In the leucocyte-depletion group, circulating leucocytes and
granulocytes were reduced, and the postoperative arterial oxygen tension was higher
one hour after arrival to the intensive care unit and after extubation. These results
suggest that leucocyte depletion of the residual heart-lung machine blood improves
postoperative lung gas exchange function and reduces the inflammatory response.
In chapter 3, a similar study is described in children presenting for congenital
heart surgery. The inflammatory response after cardiopulmonary bypass in children is
more severe than in adults. In addition, cyanotic children are also more vulnerable to
oxygen radicals. We therefore expected a better clinical effect of leucocyte depletion
of the residual heart-lung machine blood in children than in adults. The residual heart-
lung machine blood was filtered with a leucocyte depletion filter in 25 children before
reinfusion. A control group of 25 children received this blood unfiltered. We measured
postoperative leucocyte counts and arterial blood oxygenation, and found that the
postoperative leucocyte counts were significantly lower in the filter group than in the
control group. This difference reached a maximum on the second postoperative day.
However, in contrast to our study in adults, there was no difference in arterial blood
oxygenation on the first postoperative day.￿
￿
￿
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Chapter 4 addresses the question whether a leucocyte depletion filter removes
activated granulocytes or a general leucocyte population. This has implications for the
efficacy of the filtration process. After clinical use, we examined 11 filters
morphologically and immunologically. In addition, b-glucuronidase was measured in 8
patients before and after the filter to determine whether leucocytes were activated
during filtration. Microscopic evaluation revealed that granulocytes were trapped
significantly more in the first blood contact layer of the filter material than in the other
layers. A maximal CD45RO expression was measured on granulocytes trapped inside
the filter material indicating that these granulocytes were activated. In contrast, the b-
glucuronidase concentration did not increase after filtration, suggesting the absence of
activation of granulocytes by the filtration process. These results suggest that a
leucocyte depletion filter removes activated granulocytes rather than leucocytes at
random and imply that a leucocyte depletion filter is suitable for use in cardiac surgical
patients.
In chapter 5 three major leucocyte filtration strategies were compared in order to
define optimal duration of the filtration procedure as well as flow and pressure
conditions in the filter. These filtration strategies were: filtration of arterial blood
throughout cardiopulmonary bypass (associated with high flow and pressure
gradients), filtration of a part of the venous return blood in the rewarming phase during
cardiopulmonary bypass (associated with intermediate flow, but high pressure),
filtration of residual heart-lung machine blood during transfusion into the patient after
cardiopulmonary bypass (associated with low flow and low pressure), and a control
group without filtration. We measured circulating leucocyte counts, plasma elastase
levels and arterial blood oxygenation, and examined filters postoperatively by scanning
electronmicroscopy. Although we could not demonstrate a clinical difference among
the three leucocyte depletion strategies, the laboratory results suggested that leucocyte
filtration at low flow and pressure conditions is associated with less leucocyte damage
and less release of elastase.
Chapter 6 gives an introduction into the concept of fat filtration. Recently, fat
microemboli have been demonstrated in brain tissue after cardiopulmonary bypass.
These were related to retransfusion of cardiotomy suction blood and associated with
postoperative neurocognitive dysfunction. Therefore, attention is again focused on the
adverse effects of retransfusion of cardiotomy suction blood during cardiac surgery. In
addition, the role of fat on organ injury may have been underestimated, because fat
microemboli have not only been demonstrated in brain tissue after cardiopulmonary
bypass, but also in lung and renal tissue.
In chapter 7 the use of a fat removal filter for surgical wound suction blood was
examined with emphasis on the efficacy of the filter in a clinical setting. We choose
wound suction blood during cardiac surgery as this blood contains a considerable
quantity of fat and particulate microemboli. Coronary artery bypass patients were
randomly divided into two groups. In one group cardiotomy suction blood was filtered
with a fat removal filter, in the other group this blood was retransfused without
filtration. Filter efficacy was evaluated using biochemical assays and thin layer
chromatography of blood samples taken simultaneously before and after the filter. In
addition, clinical and biochemical markers for organ injury were determined in both
groups. The fat filter removed 40% of fat, leucocytes and platelets from cardiotomy
suction blood. Chromatography showed a significant reduction in free fatty acids,￿
￿
￿
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phospholipids and triglycerides. Clinically, leucocyte counts were similar, but platelet
counts were higher in the filter group on the first postoperative day. Although from
this small scale study fat filtration appeared promising, a larger study is necessary to
determine the clinical effects on organ injury.
In chapter 8 the fat filter was used for the cardiotomy suction blood during cardiac
surgery, but emphasis was put on cerebral effects and on the inflammatory response. In
one group of coronary artery bypass patients the cardiotomy suction blood was filtered
with a fat removal filter and retransfused, in the other group the cardiotomy suction
blood was completely discarded. We measured triglyceride and glycerol, and neuron-
specific enolase and S-100b as brain injury markers, and circulating total white blood
cell and granulocyte counts and interleukin-6 as inflammatory markers. Apart from a
transient increase in S-100b and neuron specific enolase values in the filter group,
there was no difference between the groups on the first postoperative day. Triglyceride
levels on the first postoperative day were similar. Total white blood cell and
granulocyte counts were higher in the filter group.
The filtration related transient increase in brain markers and the higher white
blood cell and granulocyte counts in the filter group suggested that the filter efficacy
should be improved.
Conclusions
In the clinical studies presented in this thesis leucocytes and fat particles were
filtered during and after cardiac surgery. The results of these studies suggest a
beneficial effect of perioperative leucocyte and fat filtration on postoperative tissue
injury. The best clinical results were achieved with the filtration of the residual heart-
lung machine blood. Filtration techniques for cardiotomy suction blood are promising.
However, it should be kept in mind that the fat filter we used was not very effective.
Therefore, with an improved filter better clinical results might be obtained.
There is evidence that leucocytes, fat and particulate all contribute to post-
operative tissue injury. The results of this thesis suggest that leucocyte, particulate and
fat filtration may be considered as one entity from an inflammatory point of view.
Therefore, from a clinical point of view, one filter suitable for the cardiotomy suction
blood as well as the residual heart-lung machine blood should be developed.￿
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De hart-longmachine vormt door zijn grote contactoppervlak met het bloed van de
patiënt een enorme prikkel voor stollings- en ontstekingsreacties. Deze ontstekings-
reacties omvatten het gehele lichaam en leiden tot weefselbeschadiging die na de
operatie gemeten kan worden. Leucocyten, ook wel witte bloedlichaampjes genaamd,
en vooral granulocyten, die een subgroep vormen van de witte bloedlichaampjes,
spelen een sleutelrol in die ontstekingsreacties. Om de postoperatieve weefselbescha-
diging te verminderen of misschien zelfs te voorkomen hebben we de aandacht gericht
op de leucocyten. We wilden hun activering zoveel mogelijk beperken. Verschillende
methoden zijn hiervoor door anderen al onderzocht, zoals het aanbrengen van een
coating op het contactoppervlak van de hart-longmachine, het gebruik van een cell-
saver om wondzuigbloed dat doorgaans weer teruggegeven wordt aan de patiënt,
schoon te wassen, het terugbrengen van het aantal vrije zuurstofradicalen en het
gebruik van farmacologische middelen als aprotinine en corticosteroiden. Echter, uit
dierexperimenten bleek een andere methode, het verwijderen van de leucocyten met
behulp van een filter, het meest effectief te zijn.
Niet alleen geactiveerde leucocyten, maar ook vet en andere deeltjes die tijdens de
operatie in de bloedbaan komen zoals luchtbelletjes, plastic van de hart-longmachine
en kleine bloedstolsels, vormen een oorzaak van postoperatieve weefselbeschadiging.
Kleine vetdeeltjes zijn na hartchirurgie in het hersenweefsel aangetoond en worden in
verband gebracht met het functieverlies dat bij ongeveer een kwart van de patiënten
drie maanden na de operatie nog bestaat. Deze vetdeeltjes zijn ook aangetoond in long-
en nierweefsel. Door verbeterde filtertechnologie kunnen nu naast de leucocyten ook
vetdeeltjes uit het bloed verwijderd worden.
Het doel van dit proefschrift is, zoals in hoofdstuk 1 is beschreven, aan te tonen
dat het wegfilteren van leucocyten en vetdeeltjes tijdens hartchirurgie leidt tot afname
van ontstekingsparameters en tot vermindering van de postoperatieve weefselbescha-
diging.
In hoofdstuk 2 wordt een nieuwe, verbeterde methode beschreven om leucocyten
te verwijderen. Tot dan werden tijdens een hartoperatie leucocyten verwijderd door
een filter dat in de toevoerlijn van de hart-longmachine naar de patiënt was geplaatst.
De resultaten daarvan waren niet eenduidig. Deze nieuwe methode richtte zich op het
restbloed dat in de hart-longmachine overblijft aan het einde van de extracorporele
circulatie en weer wordt teruggegeven aan de patiënt. Alleen dat bloed werd nu
gefilterd. Wij onderzochten in een gerandomiseerde prospectieve studie bij 30
patiënten of deze nieuwe methode tot een verbetering van de longfunctie en een
afname van de postoperatieve ontstekingsreactie zou leiden. In de filtergroep werden
vóór teruggave aan de patiënt de leucocyten met een filter uit het restbloed van de hart-
longmachine verwijderd. In de controlegroep werd een zelfde hoeveelheid rest-bloed
ongefilterd teruggegeven. De patiënten in de filtergroep hadden minder leuco-cyten en
granulocyten in hun bloed. Daarnaast hadden zij een uur na aankomst op de intensive
care en na het ontwennen van de beademing een significant hogere zuurstof-spanning
in het bloed. Deze resultaten duiden erop dat het wegfilteren van de witte
bloedlichaampjes uit het restbloed van de hart-longmachine postoperatief inderdaad
leidt tot een verbetering van de gaswisseling in de longen en tot een afname van de
ontstekingsreactie.
In hoofdstuk 3 wordt een gelijksoortige studie beschreven bij kinderen die een
hartoperatie ondergingen voor de correctie van een aangeboren hartafwijking. Bij￿
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kinderen is de ontstekingsreactie bij gebruik van de hart-longmachine meer
uitgesproken dan bij volwassenen. Dat komt in de eerste plaats omdat bij kinderen het
contactoppervlak van het bloed met het inwendige van de hart-longmachine relatief
groter is dan bij volwassenen. Daar komt nog bij dat kinderen met een cyanotische
hartafwijking gevoeliger zijn voor de effecten van vrije zuurstofradicalen die ook
bijdragen aan de ontstekingsreactie. We verwachtten daarom bij de kinderen een meer
uitgesproken klinisch effect van het filteren van het restbloed uit de hart-longmachine
dan bij de volwassenen. Bij 25 kinderen verwijderden we met een filter de leucocyten
uit het restbloed van de hart-longmachine voordat we het bloed weer teruggaven. De
resultaten vergeleken we met een controlegroep van 25 andere kinderen die dit
restbloed ongefilterd terugkregen. We vonden dat het aantal leucocyten in de
filtergroep significant lager was dan in de controlegroep. Het verschil was, in
tegenstelling tot de bevindingen bij de volwassenen de tweede postoperatieve dag,
maximaal. We konden echter, in tegenstelling tot de bevindingen bij de volwassenen,
op de eerste postoperatieve dag geen verschil waarnemen in de arteriële zuurstof-
spanning in het bloed. Onze verwachting, dat het klinische effect van bloedfiltratie
groter zou zijn bij kinderen, werd dus slechts gedeeltelijk bevestigd.
In hoofdstuk 4 gaan we in op de vraag of een filter alle leucocyten verwijdert of
alleen de geactiveerde. Dat zou gevolgen hebben voor de wijze waarop men een filter
zou moeten inzetten. We onderzochten hiertoe 11 commercieel verkrijgbare filters. Na
gebruik vonden we significant meer granulocyten in de eerste laag van het
filtermateriaal dat met het bloed contact maakt dan in de volgende lagen.
Immunologisch onderzoek toonde aan dat de expressie van het adhesiemolecuul
CD45RO op de celmembraan van de granulocyten, die in het filter zaten, maximaal
was. Dat betekent dat deze granulocyten geactiveerd waren. Daar staat tegenover dat
de concentratie van het b-glucuronidase die gemeten was vóór en na het filter, niet
verschilde. Dat duidt erop dat het filtermateriaal zelf de granulocyten niet activeerde.
Deze resultaten suggereren dat een leucocytenfilter inderdaad alleen de geactiveerde
granulocyten wegvangt, hetgeen betekent dat toepassing van een leucocytenfilter nuttig
kan zijn om een ontstekingsreactie te verminderen.
Om inzicht te krijgen in de optimale duur van de filterprocedure en de effecten
van de bloedstroom en de drukverhoudingen in het filter, vergeleken we in hoofdstuk 5
drie methoden om leucocyten weg te filteren. Die methoden zijn: (1) het filteren van
bloed in de arteriële toevoerlijn van de hart-longmachine (met hoge bloedstroom en
hoge drukgradiënt), (2) het filteren van een deel van het bloed uit de veneuze
afvoerlijn van de hart-longmachine (met middelmatige bloedstroom en hoge druk-
gradiënt) en (3) het filteren van het restbloed uit de hart-longmachine na extra-
corporele circulatie (met lage bloedstroom en lage drukgradiënt). In een vierde
patiëntengroep werd geen filter toegepast. Dit was de controlegroep. We vonden geen
verschil in klinische uitkomst tussen de drie methoden. Wel duidde laboratorium-
onderzoek erop dat het filteren van leucocyten bij lage bloedstroom en lage druk de
minste schade veroorzaakte aan de leucocyten.
In hoofdstuk 6 worden als inleiding tot de volgende hoofdstukken enkele aspecten
van het filteren van vetdeeltjes besproken. Vetten lossen slecht op in bloed en vormen
daar deeltjes. Na hartchirurgie waarbij de hart-longmachine werd gebruikt, zijn
dergelijke vetdeeltjes aangetoond in onder andere de hersenen, longen en nieren van
patiënten. Deze vetdeeltjes worden rechtstreeks in verband gebracht met de￿
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beschadiging in functie die bij veel patiënten na hartchirurgie aantoonbaar is. Men
vond deze vetdeeltjes ook terug in het wondzuigbloed dat tijdens de operatie veelal
direct weer wordt teruggeven aan de patiënt. Hiermee is de aandacht gevestigd op een
nadelig effect van het teruggeven van het wondzuigbloed tijdens de operatie.
In hoofdstuk 7 onderzochten we bij coronaire bypass operaties de effectiviteit van
een vetfilter voor het chirurgische wondzuigbloed. Dat vetfilter was afgeleid van een
leucocytenfilter. In de filtergroep werd het wondzuigbloed vóór teruggave aan de
patiënt gefilterd. De resultaten werden vergeleken met een controlegroep waarin het
wondzuigbloed ongefilterd werd teruggegeven. De effectiviteit van het filter werd
beoordeeld aan de hand van chromatografie en van biochemische bepalingen van
bloedmonsters die tegelijkertijd vóór en na het filter werden afgenomen. Het vetfilter
verwijderde 40% van het vet, maar ook 40% van de leucocyten en bloedplaatjes uit het
wondzuigbloed. In de bloedmonsters na het filter werd met chromatografie eveneens
een significante afname gevonden van de vrije vetzuren, de fosfolipiden en de
triglyceriden. Het aantal leucocyten in het bloed was in beide groepen niet verschillend
op de eerste postoperatieve dag. Wel was het aantal bloedplaatjes in de filtergroep
hoger. Deze resultaten tonen aan dat het filteren van vetten in de kliniek mogelijk is,
en dat er naast vetten ook andere belangrijke bloedelementen tegelijkertijd verdwijnen.
De effectiviteit van het vetfilter lijkt echter voor verbetering vatbaar.
In hoofdstuk 8 beschrijven we bij patiënten, die een coronaire bypass operatie
ondergingen, enkele effecten van het gebruik van het vetfilter voor het wondzuigbloed,
op de hersenen en op de postoperatieve ontstekingsreactie. In de filtergroep werd het
wondzuigbloed vóór teruggave aan de patiënt gefilterd. In de controlegroep werd het
wondzuigbloed helemaal niet meer teruggegeven. Als indicator voor schade aan de
hersenen bepaalden we de bloedspiegels van de enzymen neuron specifieke enolase en
S-100b. Als indicator voor de mate van de ontstekingsreactie bepaalden we de
hoeveelheid leucocyten en granulocyten in het bloed alsmede de cytokine Inter-
leukine-6. Afgezien van een kortdurende toename in het bloed van de enzymen neuron
specifieke enolase en S-100b vonden we op de eerste postoperatieve dag geen
verschillen tussen beide groepen. De aantallen leucocyten en granulocyten in het bloed
van de filtergroep waren echter hoger dan in de controlegroep, waaruit we
concludeerden dat de effectiviteit en de capaciteit van het filter zeer beperkt waren.
Conclusies
In de klinische studies, die beschreven zijn in dit proefschrift, werden leucocyten
en vetdeeltjes op verschillende wijze tijdens of na een hartoperatie, uit het bloed
gefilterd. De resultaten van die studies duiden er op dat perioperatieve filtratie van
bloed inderdaad een gunstig effect heeft op de weefselbeschadiging en op de ont-
stekingsreacties na een hartoperatie. De beste klinische resultaten met betrekking tot
weefselbeschadiging en ontstekingsreacties werden behaald met de techniek waarbij
het restbloed van de hart-longmachine werd gefilterd. Verbeteringen aan het vetfilter
zullen enkele nadelige effecten van de huidige filters verder moeten doen verminderen.
Uit praktische overwegingen zou gestreefd moeten worden naar het ontwikkelen van
één type filter, waarmee zowel het wondzuigbloed als ook het restbloed van de hart-
longmachine kan worden gefilterd.￿
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